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ABSTRACT 
DETERMINANTS OF DELAYED TUBERCULOSIS CASE FINDING IN PRIMARY 
HEALTH CARE CLINICS, MAKANA MUNICIPALITY, EASTERN CAPE 
BACKGROUND: The prevalence of tuberculosis (TB) has been rapidly on the 
ascendency in the recent years globally due to its co-infection with HIV/AIDS. TB 
case finding is one of the technical pillars of the Directly Observed Treatment Short 
course (DOTS) TB strategy and there has been advocacy for early TB case 
detection to be the new focus of TB control efforts.  
PURPOSE: The purpose of this non-experimental study was to assess the 
determinants of TB case finding among pulmonary TB patients registered for treatment 
in Makana Municipality 
METHOD: A quantitative, non-experimental, cross sectional descriptive study among 
PTB patients registered for treatment at the primary health care clinics in Makana 
Municipality was done. Data collection was by self-administered questionnaires while 
sampling was by systematic sampling of PTB patients at five systematically selected 
clinics.  
RESULTS: Patient–related delay contributed more to total delay, in this study 
sample, than health system-related delay.  Health system delay was found to be 
significantly associated with poorer finances, passive smoking history, seeking care 
from multiple health providers, initially visiting a non- NTCP health provider, TB 
stigma , overcrowding in the household and having difficulty with breathing as an 
initial symptom (p<0.05). 
CONCLUSION: There was a significant delay in TB case finding among PTB 
patients in this local municipality and patient related determinants contributed more 
than health system related determinants to this delay. There is need for the 
municipal TB programme to embark on an aggressive health education programme 
to furnish the populace with accurate information about TB, improve their health 
seeking behaviour and help address the issue of stigma associated with TB.  
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 CHAPTER 1  
ORIENTATION OF THE STUDY 
1.1 INTRODUCTION 
Tuberculosis (TB) is a potentially fatal disease caused by bacteria, Mycobacterium 
tuberculosis, which affects many parts of the body (Centres for Disease Control and 
Prevention, 2009: 8). The commonest form of TB is pulmonary tuberculosis (PTB), a 
droplet infectious disease involving the lung parenchyma and is easily transmitted 
when an infected person expels TB bacteria. If TB is left untreated in any part of the 
body it can be fatal. The prevalence of TB has been rapidly on the increase because 
it is the commonest opportunistic infection associated with HIV/AIDS (Stop TB 
Partners, 2011:1; USAID, 2009:8). South Africa ranks 3rd amongst the countries worst 
hit by TB burden in the world, contributing 500,000 new TB cases in 2011 (WORLD 
HEALTH ORGANIZATION, 2012: 10-11) while the Eastern Cape Province, with 
62,000 new TB cases, is second hardest hit among the provinces in South Africa (Day, 
Gray, & Budgell, 2011:168; Health Systems Trust, 2013). 
Management of TB is one of the top strategic priorities for the health system in South 
Africa (National Department of Health (NDOH) 2007:6). Despite the improvement in 
the Directly Observed Treatment Short- course (DOTS) coverage in the country to 
100% coverage (NDOH, 2007:12), the growing burden of TB infection and death in 
the South Africa are yet to be controlled (WORLD HEALTH ORGANIZATION, 
2012:10-11). The STOP TB Partners (Stop TB Partners, 2011:25) emphasize the need 
to strengthen TB control determinants and not just concentrating on only medical 
treatment of TB. Preventive measures including early case finding was stressed as 
crucial for curbing TB infection, especially PTB infection. TB case-finding in South 
Africa is based on the use of internationally approved DOTS strategy of systematic 
screening of symptomatic patients presenting at the health facilities (passive-case 
finding) (NDOH, 2009:18). Unfortunately, TB cases do not present directly to public 
TB clinics, rather they present to other health care settings or stay at their homes to 
seek alternative care (WORLD HEALTH ORGANIZATION, 2006a:5-10, NDOH-
Arizona, 2007:5.8). Consequently, there are delays in detecting these TB cases for 
prompt and effective treatment. Delayed TB case-finding hampers effort at controlling 
TB particularly in South Africa (Liu, Wilson, Dawood, Cameron, & Alvarez, 2012:3). 
These delays has been reported, among other things, to contribute to increase in 
infectiveness in the community (Wood, Lawn, Johnstone-Robertson & Bekker, 
2010:113; WORLD HEALTH ORGANIZATION, 2006a:11) thereby perpetuating the 
high TB burden. Determinants, including patients’ and health system determinants 
have been identified as major contributing determinants (Storal, Yimer & Bjune, 
2008:1, 3; Finnie, Khoza, Van den Borne,  Mabunda, Abotchie & Mullen., 2011:397-
406). Sustained progress in TB control programme in resource-limited settings 
requires establishing the level of delays and the setting-specific patient and health 
system determinants that influence delays in finding TB cases (WORLD HEALTH 
ORGANIZATION, 2006a:11-12). These are important first steps in identifying points 
of intervention in TB care and control (Finnie et al., 2011:395). 
This study set out to investigate the delays in TB case finding among PTB patient 
registered for treatment at the primary health care (PHC) clinics in Makana 
Municipality and to describe the determinants contributing to these delays. 
1.2 BACKGROUND TO THE STUDY 
TB is a global health crisis and a growing health threat in the world today. The WORLD 
HEALTH ORGANIZATION reports that 1 in every 3 persons in the world already has 
(latent) TB infection (STOP TB Partners, 2011:v). Approximately 10% of this latent TB 
cases develops into active TB, which without treatment, result in an estimated case-
fatality rate of 60% (World Bank, 2006:290, 291). Studies on natural history of TB show 
that, left untreated, 70% of smear-positive TB cases and 20% of smear-negative TB 
cases die within 10 years of the infection (WORLD HEALTH ORGANIZATION, 
2011a:3). The WORLD HEALTH ORGANIZATION declared TB a global health 
emergency in 1993 due to the steady rise in TB disease in the whole world (WORLD 
HEALTH ORGANIZATION, 2011a:3). At the time, over 7 million new TB cases were 
identified and 1.35 million people had died of TB in the world. Efforts have been made 
at reducing the scourge of TB infection through the development of the DOTS strategy 
in 1995, and the introduction of International Standard for TB Care (Migliori, Hopewell, 
Blasi, Spanevello & Raviglione, 2006 :687-689), yet, the burden of TB in many 
countries remains a catastrophe, requiring urgent measures (WORLD HEALTH 
ORGANIZATION, 2006b:9-12; WORLD HEALTH ORGANIZATION, 2011a:10,13; 
WORLD HEALTH ORGANIZATION, 2012:10-11). According to the WORLD HEALTH 
ORGANIZATION Global Tuberculosis Report (WORLD HEALTH ORGANIZATION, 
2012: 3, 9), there were an estimated 8.7 million incident cases of TB and 1.4 million 
deaths globally in 2011. TB infection is currently the second leading cause of death in 
the world among the infectious disease category (WORLD HEALTH ORGANIZATION, 
2012:3), with Africa and Asia disproportionately bearing the brunt of the epidemic. The 
global TB epidemic stabilized and is said to be currently on the decline but this decline 
is more of a developed world’s phenomenon (WORLD HEALTH ORGANIZATION, 
2012: 12). 
South Africa had the highest TB incidence rates (993 per 100,000 populations) in the 
world in 2011 (WORLD HEALTH ORGANIZATION, 2012: 10-11), a rate the WORLD 
HEALTH ORGANIZATION described as being of a serious epidemic proportion. 
Among the 22 countries with highest TB burden, South Africa ranks 3rd behind India 
and China (WORLD HEALTH ORGANIZATION, 2012: 10-11) but these other two 
countries have populations which are much  bigger  than that of South Africa. The first 
TB case was spotted in South Africa in the 17th century and became widespread in the 
19th century (Abdool Karim, Churchyard, Abdool Karim & Lawn 2009:3-4). Following 
the advent of HIV/AIDS, the new TB cases in South Africa has more than quadrupled 
from 110,000 (301 per 100 000 populations) in 1990 to 500,000 (993 per 100,000 
populations) in 2011, and TB-related deaths more than doubled from 14,000 deaths 
(38 per 100,000 populations) to 25,000 death (50 per 100,000 populations), over the 
same period (WORLD HEALTH ORGANIZATION, 2012:10-11; WORLD HEALTH 
ORGANIZATION, 2010:72; WORLD HEALTH ORGANIZATION, 2011a:12-13, 125). 
The majority of TB infection in South Africa affect young people aged between 30-39 
years and who are living in the townships and informal settlements (NDOH, 2011:24) 
Currently, TB is the leading cause of death in South Africa (Wilson, Howel,Toppozini, 
Dong, Clark & Hurtado, 2011:1102). 
The Eastern Cape Province has one of the worst TB statistics in South Africa. The 
Province has a high incidence rate of TB with about 62000 new cases recorded in 
2010 alone (Day, Gray, & Budgell, 2011:168; HST, 2011) while TB related deaths were 
put at 167 deaths per 100,000 population in 2009 (Day & Gray, 2013: 228). 90% of 
these TB cases are PTB, indicating high proportion of infectious TB cases (Day, Gray, 
& Budgell, 2011:168). Cure rate in Eastern Cape was 66% in 2009, well below the 
South African average (71%) and the WORLD HEALTH ORGANIZATION target of 
85% (Day, Gray, & Budgell, 2011:169; Day, Barron, Massyn, & Padarath, 2011:93). 
Cacadu District presents a peculiar situation. Despite having a TB cure rate of about 
72% in 2009 (Day, Barron, Massyn and Padarath. 2011, 2011:90) which was above 
the Provincial average, it was, paradoxically, the district with the second highest TB 
incidence rate (1383 per100,000 populations) in South Africa in 2010 (Day et al., 
2011:89). This suggests that TB cases are not detected early enough to reduce 
transmission rate, hence, it was suggested that there is the need to investigate the 
issues around TB case finding in Cacadu district (HST, 2009:98). 
 
Table 1.1 Tuberculosis related statistics of South Africa, Eastern Cape and 
Cacadu District 
 1990 2009 2010 2012 
South Africa     
New TB infection a 110,000 a  500,000 a 530,000 a 
Incident rate per 
100,000 population 
301 a  981 a 1000 a 
TB-related deaths a 14,000  25,000 31,000 a 
Cure rate b 40% (in 1995) 
a 
71% a 74% a 74% a (in 
2011) 
Eastern Cape     
New TB infection 56,495 (in 
2000) e 
63,807 b 62,029 b 60,046 b (in 
2011) 
Incident rate per 
100,000 population b 
 948.2  919.8  902.3 (in 
2011) 
TB-related deaths per 
100,000 population b 
154 (in 2003) 173 (in 
2008) 
167 (in 
2009) 
 
Cure rate  50.7 (in 2003) 
f 
66% b 67.1% b  
Cacadu district     
TB incident rate per 
100,000populations  
  1383 d 1029 c 
Cure rate  39.1 f (in 
2003) 
72% d 70.4%d 75.1% c (in 
2011) 
Source a- WORLD HEALTH ORGANIZATION, 2013: 148,168; b- Day and Gray, 
2013:228-229; c: Massyn, Day, Dombe, Barron, English, and Padarath, 2013:184, 
200; d- Day, Barron, Massyn, Padarath, and English. 2011:89-90; e: Antoinette, 
2000:343; f: Day, Monticelli, vermaak, okorafor, Moodley and DoHerty. 2006: 107,111. 
TB case finding is one of the technical pillars of the DOTS strategy fundamental to the 
prevention and control of TB (WORLD HEALTH ORGANIZATION, 2006b:9-10).  It is 
an important step that leads to prompt initiation of anti-TB treatment which will reduce 
TB infectiousness and overall burden of the infection (WORLD HEALTH 
ORGANIZATION, 2006b:9-10; Department of Health (DOH), 2012:2.7). Progress in 
TB case finding has been made worldwide. Globally, 65% of estimated incidence was 
detected in 2010, and in South Africa, TB case finding rose from 59% in 2000 to 72% 
of estimated incidence in 2010 (WORLD HEALTH ORGANIZATION, 
2011a:116&128).  For long, though, emphasis has been focused more on increasing 
the number of cases detected. This is because assessment of performance of case 
finding efforts has always focused on measurement of the number of cases diagnosed 
as a function of estimated incidence (WORLD HEALTH ORGANIZATION, 2011a:28-
36) rather than on how early these cases are detected. However, due to continued 
high rates of new TB infection and high mortality rates, emphasis should now shift to 
early case finding (NDOH, 2011:36; Day et al., 2011:89). 
Delayed TB case-finding is a factor that hinders efforts at reducing TB burden 
(WORLD HEALTH ORGANIZATION, 2006a:5-10).  Delayed TB case finding is a 
global problem (Sreeramareddy, Panduru, Menten & Van den Ende, 2009:1), a health 
challenge in Africa (Sendagire, Schim van der Loof, Mubiry, Kende-Lule, &Cobelens, 
2010:1) and in South Africa (Liu, Wilson, Dawood, Cameron, & Alvarez, 2012:3). 
Recent studies (Wilson et al., 2011:1102; Shapiro, Variava, Rakgokong, Moodley, 
Luke, Salini, Chaisson, Golub& Martinson, 2012:1) show that TB in South Africa is 
diagnosed too late for effective treatment, both to save life and to prevent infectivity in 
the community. Wood et al., (2010:113) further stated that in high TB transmission 
settings (such as South Africa), “lower case finding and delays in diagnosis…result in 
on-going transmission”. The WORLD HEALTH ORGANIZATION (2006a:5-11) notes 
that 35% of TB contacts would have become infected by the time a smear-positive 
index case is diagnosed. Other consequences of delayed TB case finding, of 
importance to public health, include more extensive disease/complications, increased 
mortality as well as worsened economic conditions for the patients and their families 
(Sendagire et al., 2010:1). Studies found delays of 90 to over 180 days to exist in 
African countries (Sreeramareddy et al., 2009:4-7; Fatiregun, & Ejeckam, 2010:1). In 
a study conducted in Nigeria, 62% of patients were found to delay for over 30 days 
before seeking for care (Fatiregun, & Ejeckam, 2010:1). 
Wilson et al. (2011:1102) affirms that the key to reducing the transmission of and death 
from TB is not the provision of new diagnostic technologies rather the effective and 
responsive management of human determinants that delay TB case finding. These 
human determinants are of critical importance for maximising TB control outcomes. 
Patient’s alertness to all symptoms of TB and having the right attitude to health seeking 
behaviours as well as health systems preparedness to diagnose TB infection is of 
importance (STOP TB Partners, 2009:4). The best TB control programme will fail if 
these important undermining determinants are not identified and addressed.  
The WORLD HEALTH ORGANIZATION (2011b:5) identified sources of delays to 
detection of TB cases to include, disease natural history delay, patient delay, access 
delay, suspect identification delay, and diagnostic delay. Prior related studies 
classified these delays into patient and health care system delays (Finnie et al., 
2011:397-406; WORLD HEALTH ORGANIZATION, 2006:11).  Critical determinants 
including patient’s knowledge of TB disease, patient’s attitudes and perception about 
TB, and patient’s own way of experiencing TB symptoms and illness, socio-cultural 
determinants were identified in systematic review studies as aspects of patient’s delay 
(Finnie et al., 2011:397). Other contributing determinants include 
residential/geographical determinants, travel time/distance to health care facilities, the 
choice of health facility/health provider to consult, and health system determinants 
including staff knowledge, staff attitude, staff workload, and coordination of TB 
services and referral systems (WORLD HEALTH ORGANIZATION, 2006:11; Finnie 
et al., 2011:397-406; Woolf, Salaniponl, & Kemp, 2006:67-68; Meintjes, Schoeman, 
Morroni, Wilson & Maartens, 2008:4-7). Despite the fact that similar studies have been 
undertaken on delays in case detection in South Africa (Skordis-Worrall, Hansen & 
Mills, 2010:171) and other countries (Fatiregun & Ejeckam, 2010:1), studies show the 
phenomenon of delayed TB case finding is a complex one in which different 
contributing determinants are in operation for different groups of TB patients in 
different settings (Fatiregun & Ejeckam, 2010:2; Mpungu, Karamagi, &Mayanja, 
2005:2). 
Finnie et al. (2011:395) noted that investigating barriers to early case finding is an 
important starting point for identification of points of intervention in planning for TB 
care and control. The WORLD HEALTH ORGANIZATION (2006a:12) suggests that 
to understand the determinants of delays in TB case finding for the entire population, 
determinants in specific segments of the population need to be investigated. There is 
paucity of data on the existence of and determinants contributing to presumed delays 
in TB case finding among PTB patients in Makana Municipality, despite a very high 
TB incidence rate in the Cacadu District. Thus, this study was designed to assess the 
level of and determinants contributing to, delayed TB case finding among PTB patients 
registered for treatment at the PHC clinics in Makana Municipality. 
 
1.3 STATEMENT OF THE RESEARCH PROBLEM 
Early TB case finding is crucial for reducing TB transmission, severity of the infection 
and mortality. However, TB cases are often detected late in the disease. Delays in TB 
case finding has been attributable to patient not seeking care early enough, and health 
services not detecting the TB cases even when the cases have presented during the 
earlier stage of the infection (Skordis-Worrall et al., 2010:177-178; Sendagire et al., 
2010:8; WORLD HEALTH ORGANIZATION,2004:8). Screening of patients for TB in 
primary health care facilities are not adequately implemented to identify cases of TB 
early enough to curb the spread of TB. TB patients, on the other hand, are not alert to 
all the TB symptoms and do not have the right health seeking behaviour. This study, 
however, intends to investigate the level of delayed TB case finding among PTB 
patients registered for treatment in Makana Municipality, and the health system- and 
patient-related determinants contributing to these delays. 
 
1.4 RATIONALE FOR THE STUDY 
The rising burden of TB infection in South Africa is a growing concern requiring urgent 
attention (WORLD HEALTH ORGANIZATION, 2012:10-11; WORLD HEALTH 
ORGANIZATION, 2011a:72). Despite the improvement in the DOTS coverage in the 
country to 100% coverage (NDOH, 2007:12), the growing burden of TB infection and 
death in the South Africa suggests that effective TB treatment programme alone 
cannot win the battle over TB (WORLD HEALTH ORGANIZATION, 2011a:12). 
Progress in controlling and mitigating the ravaging effect of TB infection in South Africa 
can be expedited if TB control programmes focuses on early case detection and 
prompt treatment (Skordis-Worral et al., 2010:171). This study is relevant because 
while emphasis continues to be on improving TB case detection, TB cases are 
detected too late both to save life and to reduce on-going infection, distress in the 
community and economic hardship (WORLD HEALTH ORGANIZATION, 2011b:1). 
There is urgent need to improve the health outcomes of TB control programmes… as 
establishing the determinants deterring early TB case finding is an important starting 
point for identification of points of intervention in planning for TB care and control 
(Finnie et al., 2011:395). There has been a call by the WORLD HEALTH 
ORGANIZATION (2006b:12) and other researchers  (Fatiregun & Ejeckam, 2010:2; 
Mpungu et al., 2005:2) for the investigation of context specific determinants that cause 
delays in TB case finding in  particular settings.  Hence the need to assess the level 
and determinants contributing to delayed TB case finding among PTB patients 
registered for treatment at the PHC clinics in Makana Municipality.  
1.5 PURPOSE OF THE STUDY 
The purpose of this non-experimental study was to assess the determinants of TB 
case finding among pulmonary TB patients registered for treatment in Makana 
Municipality. The study also sought to investigate the determinants contributing to 
these delays in TB case-finding. Both patient- and health care system-related 
determinants contributing to this delay in TB case finding among PTB patients 
registered for treatment at the primary health care clinics in Makana municipality were 
assessed. 
1.6 RESEARCH OBJECTIVES 
 
The research objectives that guided this study were 
 
 To assess the time duration of delay in TB case finding among PTB patients in 
Makana Municipality 
 To identify patient-related determinants contributing to delays in TB case finding 
among PTB patients registered for treatment in Makana Municipality. 
 To identify the health system-related determinants contributing to delays in TB 
case finding among PTB patients registered for treatment in Makana local 
Municipality. 
 To suggest recommendations on practical interventions to mitigate delay TB 
case finding. 
1.7 RESEARCH QUESTION 
 
To achieve the purpose of the study, the researcher addressed the following 
questions: 
 What is the level of delay in TB case finding among PTB patients registered for 
treatment in the PHC clinics in Makana Municipality? 
 What are the patient- related determinants contributing to delays in TB case 
finding among PTB patients registered for treatment in Makana Municipality? 
 What are the health system- related determinants contributing to delays in TB 
case finding among PTB patients registered for treatment in Makana 
municipality? 
1.8 RESEARCH SETTING 
 
The study was conducted at the PHC clinics in Makana Municipality situated at the 
eastern part of Cacadu district in the Eastern Cape Province.  According to the latest 
census figures (Statistics South Africa, 2012), as at 2011, Makana municipality had a 
population of 80, 390 with an average household size of 3.4 persons. It had a 
population growth rate of 0.65%, with the majority (about 70%) of the population aged 
between 15-64 years. There is an overall unemployment rate of 32.5% in the 
Municipality which is higher than the national average (29.8%), with the youth being 
worse affected (42.3% unemployment rate). Overall, about 44% of those aged 
between 15-64 years depend on others or the government’s welfare program for their 
livelihood. 6.3% of the populace had no form of formal education while only 11.9% had 
higher education. 15% of the households live in informal dwellings with almost half 
(44.5%) of them female-headed. Half of the households have piped water within their 
dwelling, just over 70% have sanitary sewage disposal system in place and about 90% 
of the households had electricity and weekly refuse removal. 
Makana Municipality is a relatively large administrative entity comprising of urbanised 
and rural population (Makana Municipality Local Economic Development Strategy, 
2009:1-2). Poverty level is quite high, with over a fifth of the households living below 
the poverty line (less than R800 per month) (Makana Municipality Local Economic 
Development Strategy, 2009:28- 34).  
The municipality has three hospitals (a district hospital, TB hospital, and psychiatric 
hospital) which support the nine PHC clinics (Joza, Alicedale, Settlers Day, Extension 
7, Anglo African, Tyantyi, Middle Terrace, Riebeck East, Raglan Road) distributed 
across the municipality.  TB treatment is a clinic-based programme in the municipality, 
like the rest of South Africa. All patients, irrespective of the place of diagnosis in the 
municipality, are referred to and receive their TB treatment at the clinics under the 
DOTS programme. During the time of study, the nine clinics in the municipality had a 
total TB case load of 590 cases. 
1.9 SIGNIFICANCE OF THE STUDY 
 
This study will make unique contributions to the body of knowledge and to the TB 
programme in Makana Municipality as well as to the TB patients. The findings of the 
research will provide current, local level data on the determinants of and duration of 
delay in TB case finding in an Eastern Cape Municipality. This may form the 
foundation of further TB research in the Municipality and may likewise, provide 
guidance to similar research in other comparable Districts in Eastern Cape Province. 
Also, the identification of health system determinants contributing to delays in TB 
case finding may engender evidence-based change in the TB control policies in the 
Municipality which may bring about speedier and more successful screening for TB 
cases. The identified profile of the typical patient with delayed TB case finding as 
well as the patient related determinants contributing to TB case finding delays may 
also effectively direct the content and target audience of TB health education 
programme in the Municipality.  
1.10 OPERATIONAL DEFINITIONS OF KEY CONCEPTS 
 
Operational definition is described as explaining the basic concepts in terms in which 
they are to be measured (Polit and Beck, 2008:760). For the purpose of this study, the 
key concepts are conceptually defined as thus: 
Determinants: According to Collins English dictionary (Collins English dictionary, 
2005:452), determinant refers to determinants or circumstances that influence 
something. In this study, determinant refers to anything that contributes to delay in 
case-finding of PTB patients. 
Health system delay: is defined as the time interval between the first presentation to 
health care facility and time of diagnosis (Storal et al., 2008: 3). In this study, health 
system delay refers to the time, in days, from first presentation to an official health 
care facility to the time of initiation of treatment. Time interval exceeding five days will 
be termed health system delay (Ngadaya,  Mfinanga, Wandwalo & Morkve 2009:3). 
Makana Municipality: In this study, Makana Municipality refers to a relatively large 
administrative entity located in the eastern part of Cacadu district in Eastern Cape, 
which comprises of urbanised and rural population (Makana Municipality Local 
Economic Development Strategy (LED), 2009:1-2). 
Municipality: According to Collins English dictionary (Collins English dictionary, 
2005:1071), a municipality refers to a city, town district or administrative unit with some 
level of local self-governance.  
Patient: According to Collins English Dictionary (Collins, 2005:1193), a patient is a 
person who is receiving medical care. In this study, a patient refers to person whom a 
medical practitioner or a health care worker has diagnosed with PTB disease (NDOH, 
2009:29) and is receiving treatment at a PHC clinic in Makana Municipality. 
Patient delay: In this study, patient delay refers to the time, in days, from the onset of 
symptoms attributable to PTB to the time of presentation to health care practices. A 
time period of more than of 30 days will be termed patient delay in this study. 
Pulmonary TB:  PTB is described as a life-threatening droplet infectious disease 
caused by mycobacterium tubercle which affects the lung parenchyma (WORLD 
HEALTH ORGANIZATION, 2011:29, STOP TB Partners, 2011:24). In this study, PTB 
refers to an infection caused by Mycobacterium tubercle which causes the 
inflammation of the lungs, commonly presenting as cough and other systemic 
symptoms, and which is spread from person to person through droplet nuclei (NDOH, 
2009:15-18 
TB Case finding : WORLD HEALTH ORGANIZATION (1968:14) describes case 
finding as an essential early step in disease control, aimed at early detection, and cure 
of conditions which have not reached the clinical stage that will spontaneously make 
one to seek medical attention.. TB case finding is however, a strategy of prompt 
detection and reporting of TB cases (Centers for Disease and Control, 2009:9-10). In 
this study, TB case finding refers to screening for PTB based on presence of 
symptoms attributable to PTB.  
Total delay: is defined as the time from onset of TB symptom to time of diagnosis 
(Storal et al., 2008:3). In this study, total delay refers to the sum of both the patient 
and health system delays. 
1.11 RESEARCH DESIGN AND METHOD 
The research methodology is the overall plan for data collection and analysis. The 
research design and methodology for this study will be discussed in greater depth in 
chapter three 
Research design 
A research design is a structural approach that guides the planning and 
implementation of the study to achieve intended goal (Joubert & Ehrlich, 2007:77; Polit 
& Beck, 2008:211). This study followed a non-experimental, cross-sectional 
quantitative study design to obtain information from the respondents.   
Study population 
The research population included all pulmonary tuberculosis patients registered for 
treatment at the primary health care clinics in Makana Municiplity. 
1.12 SCOPE OF THE STUDY 
The study focused on delays in passive TB case-finding and contributing 
determinants, on the basis that TB control in South Africa depends mainly on passive 
case-finding. The study was conducted in the health care clinics in Makana 
Municipality among TB patients registered for treatment. 
1.13 ETHICAL CONSIDERATION 
Ethics measures the extent a given study abides by the legal, social and professional 
rules (Polit & Beck, 2008:753). Ethical rigors need to be adhered to for every research 
process, to demonstrate the integrity of the research process and protect the welfare 
of both the respondents and those the findings of the study may affect (Terre Blanche, 
Durrheim & Painter; 2006: 61; Houser, 2006: 66). Every research needs to adhere to 
some ethical standards starting from the identification of the research problem, 
through the conduct of the research to the publication of the research findings. The 
ethical considerations include protecting the right of the respondents, protecting the 
right of the institution and ensuring the scientific integrity of the research. 
The details of ethical consideration for this study are presented in chapter three. 
 1.14 STRUCTURE OF THE DISSERTATION 
 
Chapter one is the orientation of the study. It gave a brief introduction of the study and 
the background to the study. It also outlined the research problem, purpose and 
objective of the study. Chapter 2 discusses the literature reviewed for the study. 
Chapter 3 gave a detailed discussion of the study design used in the study and the 
methodology. Chapter 4 covers data analysis and the data presentation. The 
concluding chapter, chapter 5, discusses the main findings of the research, the 
limitations of the study and provides feasible recommendation for future research and 
practice. 
 
1.15 CONCLUSION 
 
This chapter provides the orientation of the study. It describes the background of the 
study, the statement of the research problem, the purpose and specific objectives of 
the study as well as the significance of the study. The chapter also gave brief 
definitions of the key terms used in the study. 
 
 
 
   
CHAPTER 2 
LITERATURE REVIEW 
2.0 INTRODUCTION    
 
A critical step that a researcher must undertake at the onset of a research process is 
to familiarize him or herself with the body of knowledge that already exists in the area 
or field of research of interest. This is the process of literature review. Burns and Grove 
(2009:92) explained that “a literature review is an organised written presentation of 
what has been published on the topic by scholars”. It refers to different forms of 
accounts or stories on existing knowledge published about the topic of interest (Barbie, 
2011:94). The emphasis is on published work which signifies that the material is 
credible within scholarly community. The core sources of information for the review of 
literature are from published, credible scholarly works which are found in journal 
articles and books but other sources include dissertations, databases, conference 
papers, policy guides, government reports, and other credible sources (Joubert & 
Ehrlich, 2007: 70). In this study, the researcher consulted a wide range of scholarly 
materials, published journal articles, books, guidelines and other “grey” literature 
(thesis, unpublished materials). 
A literature review process serves the crucial purpose of identifying other people 
working in the area /field of interest; increasing the researcher’s breadth and depth of 
knowledge on the respondents of interest; identifying theories addressing the 
respondents of interest and providing guidance in the analysis and interpretation of 
research findings (Barbie, 2011:94; Joubert & Ehrlich, 2007:66-74. In this study, the 
researcher conducted a review of literature to gain in-depth insight and obtain various 
account on issues relevant to the respondents matter of delays in TB case finding and 
determinants driving it. The literature review also helped the researcher to identify the 
theoretical framework that anchors the study in this field as well as to determine the 
suitable research process for the study.   
 
 
 
2.1 OVERVIEW OF TUBERCULOSIS.  
 
Tuberculosis (TB) is a disease caused by five closely related bacteria of the class 
mycobacteria namely Mycobacterium tuberculosis, Mycobacterium bovis, 
Mycobacterium africanum, Mycobacterium microti and Mycobacterium caneti but by 
far the commonest cause of TB worldwide is Mycobacterium tuberculosis (NDOH, 
2009: 15; World Bank, 2006:290). Mycobacterium tuberculosis is infectious and 
typically affects the lung parenchyma (PTB) but can also affect other body parts (extra-
pulmonary TB) (WORLD HEALTH ORGANIZATION, 2011a:3; CDC, 2009: 8). PTB is 
the commonest form of TB, occurring in 70- 90% of the cases (World Bank, 2006:290). 
PTB is the type of TB that can be easily spread from an infected person to another 
person by coughing, sneezing or singing (NDOH, 2009:15) which releases the droplets 
(small particles containing a number of air-borne Mycobacterium tuberculosis) into the 
air which may be inhaled by another individual in close and prolonged proximity to an 
infected person. Transmission occurs more indoors, in dark, damp spaces where the 
droplet nuclei may remain airborne for longer periods of time (NDOH, 2009:15).   
On the average, most Mycobacterium tuberculosis infections will not develop into TB 
disease (this is latent TB). It is estimated that there is only a 10% lifetime risk of 
developing TB in HIV negative patients (World Bank, 2006: 290). The situation is 
different, however, in HIV positive patients who have an average annual risk of 
developing TB of 10% (NDOH, 2009:15). Individuals with latent TB are not infectious 
because they do not have bacteria which are growing and hence cannot transmit TB 
(NDOH, 2009:15) 
TB manifests itself in a variety of symptoms such as persistent cough (of more than 2 
weeks duration), sputum production, haemoptysis (blood in sputum), fever of more 
than 2 weeks, drenching night sweats, loss of appetite, unexplained weight loss (of 
more than 5kg in a month), a general feeling of illness (malaise) and tiredness, 
shortness of breath, chest pain (NDOH, 2009: 18).  
The most common method for diagnosing TB worldwide is by testing for 
Mycobacterium tuberculosis in the sputum samples examined under the microscope 
(WORLD HEALTH ORGANIZATION, 2011a:3). Those patients who have TB disease 
and whose sputa show up the TB bacteria are described as smear positive TB cases 
and this category of TB patients have the greatest chance of transmitting the droplets, 
especially if they have cavities in their lungs (NDOH, 2009:15). In countries (including 
South Arica) with more sophisticated laboratory services, other means of diagnosis 
include the culture of Mycobacterium tuberculosis  in sputum (the gold standard of TB 
diagnosis) or using rapid molecular test methods (WORLD HEALTH 
ORGANIZATION, 2011a:3). In South Africa, confirmation of TB diagnosis is done 
using at least two sputum specimens for bacteriological confirmation (NDOH 2009:18). 
It is best that these are early morning specimen.  In a patient with clinical symptoms 
of TB that are unresponsive to antibiotics treatment, and in whom the first two sputum 
tests are negative, a 3rd sputum specimen is sent for bacterial culture. 
Studies on natural history of TB show that, left untreated, 70% of smear-positive TB 
cases and 20% of smear-negative TB cases die within 10 years of the infection 
(WORLD HEALTH ORGANIZATION, 2011a:3). Fortunately, TB, if detected early, in 
most cases, is a curable disease. (Stop TB, 2011:1).  Using a combination of first line 
drugs introduced from the 1950’s to the 1980’s, up to 90% of people with drug 
susceptible TB can be cured in six months (Stop TB, 2011: 1).Treatment of drug 
resistant TB requires more drugs (second-line drugs) and is more challenging. 
From the fore-going, it is evident that TB is a disease which has been well studied and 
understood (World Bank, 2006:290-295). Pulmonary TB is, without doubt, the most 
important form of TB as it is both the most infectious and most commonly occurring. 
TB symptoms are well known and the methods of detecting/diagnosing it are known 
and available in the South African health care system. Despite this, the TB epidemic 
continues to worsen (WORLD HEALTH ORGANIZATION, 2012:3, 10, 11). This study 
will focus on the determinants affecting delay in Pulmonary TB case finding in a South 
African municipality. 
 
2.2 EPIDEMIOLOGY OF TB 
2.2.1 Epidemiology of TB globally 
According to the WORLD HEALTH ORGANIZATION Global Tuberculosis Report, 
there were an estimated 8.7 million incident cases of TB and 1.4 million deaths globally 
in 2011 (WORLD HEALTH ORGANIZATION, 2012: 3, 9). Twenty two countries (of 
which South Africa is one) were designated as TB HBC (High Burden Countries) by 
the WORLD HEALTH ORGANIZATION in the year 2000 and jointly, accounted for 
82% of all estimated new cases in the world in 2011.The burden of TB is greatest in 
Asia and Africa with the world’s most populous nations (India and China) accounting 
for about 40% of the world’s TB cases. Africa has roughly 25% of the global TB burden 
and on per capita basis, has the world’s highest TB mortality rate (WORLD HEALTH 
ORGANIZATION, 2012:9).  Globally, the incidence of TB stabilized between 1990 and 
2001 (WORLD HEALTH ORGANIZATION, 2012: 12) and then declined. In the 2010-
2011 period, the average global decline rate was approximately 2.2%, being fastest 
(8.5%) in the WORLD HEALTH ORGANIZATION European region and slowest (2.0%) 
in the South-East Asian Region.  As cheering as this reported global decline in 
incidence may sound, it is important to note that the WORLD HEALTH 
ORGANIZATION based its estimates heavily on vital registration system. But this 
source of primary data is unreliable especially in poor, rural communities like the 
setting of the present study. For example, in 2009, it was found that 32.1% of death 
certificates submitted at the Home Affairs Department in Cacadu District in South 
Africa could not be used for public health analysis (Massyn, Day, Barron, Haynes, 
English & Padarath, 2013:194). It is therefore possible that the incidence of TB is 
hugely understated globally. In fact, the South African Health Review 2012/2013 (Day 
& Gray, 2013:227) went as far as saying that the said WORLD HEALTH 
ORGANIZATION report on global TB decline represented “a perfect example of how 
averages can obscure real problems” 
2.2.3 Epidemiology of TB in South Africa.  
 
South Africa has been reported by many researchers to have one of the highest 
prevalence and incidence TB rates in the world (WORLD HEALTH ORGANIZATION, 
2012: 10-11). There have been suggestions (Abdool Karim et al., 2009:3-4) that TB 
arrived with the European settlers and colonialists in South Africa in the 17th Century. 
At that time, the colonialists were said to have been escaping from TB which was a 
scourge ravaging Europe and Northern America. The hope then was that the sun and 
relatively purer air of South Africa would be a cure for the TB. The local, indigenous 
South African population which was previously unexposed then quickly developed TB. 
This was further worsened by later socio-political and economic events that 
subsequently unfolded. The overcrowded living conditions in the hostels, poor wages, 
poor nutritional status and the migrant labour system which characterized the mining 
sector at the time contributed to the spread of TB. This claim was supported by a study 
(Stuckler, Basu, Mckee & Lurie, 2011: 524) which seemed to suggest that silica dust 
(especially from gold dust) predisposes to increased risk of pulmonary TB and that the 
circular migration of workers to and from the mining fields and their far flung families 
in the homelands hastened the geographical spread of TB and also disrupted the 
detection and treatment of TB. Furthermore, the apartheid policies did little to curb the 
spread of TB, and in cases may have contributed to the increase in TB rates. There 
was rural poverty, unjust restriction of access to health care, banishment of those with 
disease to their original rural homes, as well as the proliferation of overcrowded 
squatter camps in peri-urban areas (HST Update issue No 56, 2000:3). Later, in the 
1980’s, the upsurge in TB/HIV led to a dramatic increase in TB rates as well as the 
development of drug resistant TB bacillus which further worsened the spread of TB.    
The South African TB situation “has reached a crisis point” (CDC, 2011) and is of 
“serious epidemic proportions” (WORLD HEALTH ORGANIZATION, 2012: 10-11).  
Following the advent of HIV/AIDS, the new TB cases in South Africa has more than 
quadrupled from 110,000 (301 per 100 000 populations) in 1990 to 490,000 (981 per 
100,000 populations) in 2010, and TB-related deaths more than doubled from 14,000 
deaths (38 per 100,000 populations) to 25,000 death (50 per 100,000 populations), 
over the same period (WORLD HEALTH ORGANIZATION, 2010:72; WORLD 
HEALTH ORGANIZATION, 2011a:12-13, 125). The latest WORLD HEALTH 
ORGANIZATION Global TB Report (WORLD HEALTH ORGANIZATION, 2012:123) 
estimated that, in 2011, TB mortality in South Africa has remained 49 per 100,000 
populations. The majority of TB infections in South Africa affect young people aged 
between 30-39 years and who are living in the townships and informal settlements 
(NDOH, 2011:24) Currently, TB is the leading cause of  deaths in South Africa (Wilson, 
Howel, Toppozini, Dong, Clark & Hurtado, 2011:1102).  
The accuracy of this relatively low TB mortality rate (49 per 100,000 populations) 
reported by the WORLD HEALTH ORGANIZATION for 2011 is challenged by the 
Statistics South Africa TB mortality data (Day & Gray, 2013: 228) in the preceding 
years (153 persons per 100,000 population in 2008 and 140 persons per 100,000 
population in 2009). There appears no logical justification for a precipitous reduction 
in TB mortality rate in South Africa as suggested by the said WORLD HEALTH 
ORGANIZATION report. For instance, TB incidence has been reported to be on the 
increase (from 971 per 100,000 in 2009 to 993 per 100,000 in 2011) (Day & Gray, 
2013: 227) and prevalence of drug resistant TB is comparatively high in South Africa 
(CDC, 2011; Day & Gray, 2013: 227). South Africa still remains, one of the twenty two 
countries designated by the WORLD HEALTH ORGANIZATION as high burden 
countries (HBC), the other twenty one being Afghanistan, Bangladesh, Brazil, 
Cambodia, China, the Democratic Republic of the Congo, Ethiopia, India, Indonesia, 
Kenya, Mozambique, Myanmar, Nigeria, Pakistan, the Philippines, the Russian 
Federation, Thailand, Uganda, the United Republic of Tanzania, Vietnam and 
Zimbabwe (Day & Gray, 2013: 227). Even among these HBC’s, South Africa ranks 3rd 
amongst the countries worst hit by TB burden in the world, contributing 490,000 new 
TB cases in 2010 (WORLD HEALTH ORGANIZATION, 2011a: 12) and is one, among 
seven HDC’s, that has not achieved the target treatment success of 85% for smear 
positive pulmonary TB (Day & Gray, 2013: 227). There is thus a possibility that the 
latest WORLD HEALTH ORGANIZATION report may have masked the severity of the 
South African TB epidemic. 
2.2.4 Epidemiology of TB in the Eastern Cape Province 
 
Eastern Cape was the province with the highest proportions of Years of Life Lost (YLL) 
due to TB and HIV in South Africa in 2009 (Massyn et al., 2013: 162). An estimated 
62,000 new TB cases occurred in the Province in 2010 (Day et al., 2011:168; HST, 
2011).  The TB death rate in the province increased steadily from 154 per 100,000 
population in 2003, peaked in 2006 at 187 per 100,000 population and has been on a 
slow decline ever since (HST, 2011) . However, the TB statistics in the Eastern Cape 
have always been worse than the national average. TB death rates were estimated at 
173 deaths per 100,000 population and 167 deaths per 100,000 populations in 2008 
and 2009 respectively compared to national averages of 153 and 140 per 100,000 in 
2008 and 2009 respectively (Day & Gray, 2013: 228). Cure rate in Eastern Cape was 
66% in 2009, well below the South African average (71%) and the WORLD HEALTH 
ORGANIZATION target of 85% (Day  et al., 2011:169; Day, Barron, Massyn, & 
Padarath, 2011:93). Similarly, percentage of TB patients completing treatment has 
improved from 60.3% in 2001 to 76.9% in 2009 but it has consistently been under-
performing compared to the national averages (65.4% in 2001 and 77.1% in 2009) 
(HST, 2011). 
Though there is reason to believe that TB related deaths have been on gradual decline 
in recent years in the province, it is also likely that the TB mortality rates reported 
above are under-estimations of the true burden of TB as they are calculated based on 
Statistics South Africa data which were neither corrected for under-reporting nor for 
coding of ill-defined causes of death (HST, 2011). Hence despite the Eastern Cape 
Provincial TB control programme recording some modest successes in the last few 
years, it is not performing nearly as well as other provincial programmes and TB very 
much remains a huge public health concern. There is thus need to investigate every 
aspect of the TB control programme to further understand why the programme is 
under-performing. 
2.2.5 Epidemiology of TB in Cacadu District 
 
Makana Municipality (the study setting) is in Cacadu District. Based on the 2009 data 
from death certificates, TB is, by far, the commonest cause of YLL in Cacadu (20.9% 
of total YLL’s) with HIV/AIDS coming a distant second at 12.1% (Massyn et al., 2013: 
194). Also, Cacadu district was the district with the second highest TB incidence rate 
(of 1 383 per 100 000) in South Africa in 2010 (Day, Barron, Massyn, & Padarath, 
2011:89). This figure, as worrisome as it may be, is still likely to be an under-estimation 
of the true TB incidence rate because the data upon which the estimates were based 
(the Electronic TB Register data) accounted for only those cases which were 
diagnosed and recorded in the health system. It is thus reasonable to assume that the 
situation is much worse 
Also concerning the TB situation in Cacadu District (Massyn et al., 2013: 194-1980), 
TB treatment defaulter rate worsened from 8.4% in 2009 to 9.0% in 2010 while the TB 
cure rate increased from 39.1% in 2003 to 78.4% in 2010 and the number of new 
smear positive TB cases showed a modest decrease from 2,023 per 100,000 of the 
population in 2009 to 1,930 per 100,000 of population in 2011. This suggests that there 
is a high number of cases of infectious (smear positive) TB cases in the district. Hence, 
the advice by the Health System Trust (2009: 98) that issues hampering TB case 
finding in Cacadu have to be investigated.    
2.3 TB CASE FINDING 
 
TB case finding is described as an organised effort to identify (and bring to treatment) 
as many TB cases as possible, in the entire community, year after year, until the 
disease ceases to be a public health problem (Centres for Disease Control, 2009:9-
10). CDC (2005:32) described case-finding as a complex process that leads to the 
presentation, evaluation, receipt of diagnosis, reporting of person with active TB and 
bringing TB patients to treatment. 
Increasingly, it is becoming evident that there needs to be a paradigm shift in the focus 
of TB control efforts and strategies. In South Africa, for example, TB control efforts 
have historically focused mainly on the proportion of TB patient effectively treated 
(Wood et al., 2005:112).Despite the increase in treatment success from 57% to 77% 
between 1999 to 2009, the TB notification rate in the country also paradoxically 
doubled over the same period (WORLD HEALTH ORGANIZATION, 2011a: 40,131). 
A plausible reason for this increase in new TB cases may be the detection of TB cases 
at advanced stages in the disease, after susceptible contacts had already been 
infected. This assumption seems to be supported by a study conducted in Cape Town 
which found a high force of transmission of TB bacilli among the study respondents 
(Wood et al., 2005:112-113; Uys, Warren, Van Heldon, 2007:1). This was due to high 
numbers of people with infectious TB and multiple exposures of contacts to many 
infectious TB cases. Early TB case detection was reported to result in shorter duration 
of infectiousness, less transmission to contacts, decreased individual morbidity and 
mortality and greater success in treatment (CDC, 2005:32). It is therefore necessary 
for the appropriate TB case detection approach to be embraced and secondly, for the 
determinants that militate against the early detection of TB cases to be explored and 
understood.  
2.3.1 Approaches to TB case finding. 
 
There are two recognized approaches to TB case finding, active and passive. Each 
has its merits and demerits but the move, in the recent years, has been towards the 
passive TB case finding approach. 
2.3.1.1 Active case finding 
 
Active case finding is described as a screening strategy targeted at the general or a 
specific population to identify presumptive TB (and initiation of treatment)  among 
individuals who have not sought diagnostic services on their own accord (WORLD 
HEALTH ORGANIZATION, 2011b: 4; Golub, Mohan, Comstock, & Chaisson, 2005: 
1183). This strategy had historically been the standard approach for TB case 
detection. There have been reports of active TB case finding programs that had 
successfully detected additional and previously undiagnosed TB cases (Golub et al., 
2005: 1184-1197).  Mass radiography was conducted in developing countries, in 1945, 
where high prevalence of TB was found among army recruits (Golub et al., 
2005:1185). Significant numbers of previously undiagnosed TB were also detected 
through mass screening of a rural Indian population of civil servants. Also a house-to 
house screening study conducted in South Korea in1969 reportedly detected three 
times more cases than the health facility screening (Golub et al., 2005:1185, 1192). 
But Active TB case finding is not without some strong criticisms. It has been described 
as a more difficult and rigorous strategy to implement on a large scale (STOP TB 
Partners, 2009:12), requires the investment of extensive financial/ human resources 
and ties up health personnel who otherwise should be useful in other health activities 
(STOP TB Partners, 2009:12; Golub et al., 2005: 1185, 1197). This re-channelling of 
scarce human and material health resources to active TB case finding efforts can have 
dire consequences in poor, developing world countries/municipalities where other 
severe public health concerns also exist. This was the point made by a study 
conducted in South Africa (Golub et al., 2005: 1195) that stated that active case finding 
may not be ideal in high TB incident settings such as South Africa. The World Health 
Organisation took a stand,on the debate of active versus passive TB case finding 
approaches. According to the WORLD HEALTH ORGANIZATION Expert Committee 
on TB (World bank, 2006:294-295), majority of smear-positive TB cases (which usually 
progress rapidly) may develop in-between the intervals of reasonable mass screening, 
and if not picked up by any other means, will increase the transmission of TB infection. 
During the 1960s and 1970s, population-wide screening was discouraged in 
developing countries by the WORLD HEALTH ORGANIZATION and restricted to 
screening of high-risk groups (Stop TB Partnership, 2009:12). A recommendation was 
then made that mass-screening may be pursued as a complementary strategy after 
appropriate effort have been made to address barriers to passive case finding 
(WORLD HEALTH ORGANIZATION, 2011b:4). 
2.3.1.2 Passive case finding 
 
Passive TB case finding is a public health strategy described as the detection of active 
TB mainly through sputum microscopy in symptomatic individuals presenting 
themselves to health services (Golub et al., 2005:1183; Stop TB Partnership, 2009:4). 
The WORLD HEALTH ORGANIZATION recommended passive case finding as the 
main approach to case finding in developing countries due to some shortcomings of 
the active case finding, some of which have been highlighted above. A facility-based 
case finding (passive case finding) programme/approach that runs indefinitely ensures 
continuous case detection. 
However, it has been found that passive case finding has not realised its full potentials. 
Passive case finding is influenced by determinants including individual (patient’s 
motivation to seek care), degree of suspiciousness by health care worker to identify 
individuals who should undergo diagnostic investigations for TB, and the quality of 
laboratory facilities (WORLD HEALTH ORGANIZATION, 2011b:4). As described by 
the WORLD HEALTH ORGANIZATION (2011b:4), the different stages involved in the 
pathway of passive case finding can potentially, serve as leakage from the chain 
leading to early case finding. These stages include (1) patient recognition of TB 
symptoms; and (2) patient accessing appropriate health service; (3) health-care-
worker identifying potential TB suspects; (4) health care worker applying the required 
step in an appropriate diagnostic algorithm; and (5) patient referral to appropriate place 
of treatment. The fault lines in the pathway to passive TB case finding can occur at 
any of the stages mentioned above. According to Golub et al. (2005:1185), studies 
conducted in developing countries found that a significant number of TB patients were 
aware of their TB symptoms and majority of those detected through mass screening 
have previously presented to health facilities for these symptom, suggesting that 
effective case finding in health services can identify symptomatic individuals. Higher 
compliance in health seeking behaviour is also believed to occur in those who have 
identified themselves as symptomatic (Dara, Grzemsk, Kimerling, Reyes & Zagorskiy, 
2009:35). Hence, it is being argued that passive case finding represent a unique 
opportunity in the TB control programme and every effort must be made to understand 
the root causes of delay in the passive case detection to enable prioritisation of action 
(WORLD HEALTH ORGANIZATION, 2011b:5). 
2.3.2 Delayed case finding 
 
Delay in TB case detection has huge implications for TB transmission dynamics, TB 
prevention and the control of TB epidemics and represents a major concern for public 
health (WORLD HEALTH ORGANIZATION, 2006a:5; Sreeramarareddy et al., 2009:8; 
Uys  et al., 2007:1,2,5). This delay has been variously defined /characterized by 
different authors. The WORLD HEALTH ORGANIZATION (2011b:5) described  Total 
TB case finding delay as comprising of 6 types of delays namely ; delay that exists 
between the development of active TB and patient recognition of symptoms (disease 
natural history delay); delay between patient recognition of symptoms and accessing 
health care (access delay); delay between patient accessing health care and 
identification of patient requiring TB test (suspect identification delays); delay between 
identification of patient requiring TB test and confirmation of diagnosis (diagnostic 
delay); and delay between the confirmation of TB diagnosis and initiation of treatment 
(treatment delay). Other authors categorised delay case finding  broadly into patient 
delay and health system delay, reflecting the duration from onset of symptom to the 
time of first consultation at a health care facility (patient delay), and the delay between 
the first consultation and initiation of treatment (Sendagire et al., 2010:1; WORLD 
HEALTH ORGANIZATION, 2006a:33).  However, irrespective of the definition given 
to “delayed TB case finding”, there is unanimity among researchers that it should be 
expressed in terms of number of days/weeks. It has been reported that for effective 
TB control, patient delay should not exceed 2-3 weeks while health system delay 
should not exceed a 5-7 days (Lambert & Van der Stuyft, 2005:954). 
Unfortunately, research conducted in both developed and developing countries, as 
well as in high and low TB endemic countries have recorded prolonged delays in TB 
case finding. The range of time delays in TB case finding have also varied greatly, 
from delays of 2-4 months  in South Africa (Storal et al., 2008:3; Wondimu, Micheal, 
Kassahum, & Getechew, 2007:148; WORLD HEALTH ORGANIZATION, 2006a:33 ), 
over  6 months in Tanzania (Sreeramareddy et al., 2009:6) and Nigeria (Fatiregun, & 
Ejeckam, 2010:3); and  over one year in California (CDC, 2005:16) 
The delay in TB case finding has serious consequences, some of which will be 
highlighted below.  
2.3.3 Consequences of delayed TB case-finding 
 
Delay in TB case detection has such significant consequences as increased risk of 
development of severe disease in patients;  reducing the success of treatment; 
extending the period of infectiousness; increasing the probability of transmission of TB 
disease to contacts/outbreaks of TB disease (CDC, 2005:32; WORLD HEALTH 
ORGANIZATION, 2006:10). A study in South Africa (Meintjes et al.., 2008:6) 
demonstrated that the need for hospitalization for in-patient TB treatment was found 
mostly among TB cases who had longer delays before diagnosis. Similar significant 
association between longer delays before diagnosis and high mortality were found by 
other studies as well (Lienhardt, Rowley, Manneh, Lahai, needham, Milligan & 
McAdam, 2001:236). 
Additionally, case finding delay has implications for members of the community to 
which the TB patient belongs. A study that evaluated the duration of TB symptoms 
before patients presented to health facility for treatment (Madebo & Lindtjorn, 1999:1) 
found that patients who were symptomatic for longer periods before presenting for 
treatment had larger number of bacilli in their sputa. Golub et al. (2006:24) noted that 
such cases that remained infectious for longer durations increased the chances of 
transmission of the infection to the community thereby perpetuating and expanding 
the epidemic to successive generations. Their study on association between total 
delays in initiation of treatment and TB transmission showed that 40% of contacts of 
those who delayed for three months and above tested positive to tuberculin skin test. 
Similar studies reported that a ship yard artisan in Maine who had active TB for 8 
months before detection resulted in 21 TB cases among his contacts (CDC, 2005:16) 
and a high school student in California who was undiagnosed for over one year 
resulted in 12 TB cases among her contacts with 23% of her other school members 
testing positive to tuberculin skin test (Centres for Disease Control, 2005:16). Wood 
et al. (2011:112-113) stated that the consequences of these delays in case finding is 
amplified in high transmission setting. They demonstrated that in setting where the 
effective contact number (defined as the number of contacts sufficient enough 
between an infectious pulmonary case and a susceptible individual to ensure TB 
transmission) is >10, delayed case finding results in transmission of TB infection to 
additional 10 contacts, while delayed case finding in settings where the force of 
infection (proportion of TB-uninfected individual newly infected per annum) is <1.0 will 
only affect the specific individual.  
In the light of dire consequences of delay TB case finding, both for the patient and 
his/her community, it is crucial that determinants that can contribute to its occurrence 
be explored and investigated. 
 2.4 THEORETICAL FRAMEWORK 
 
 To provide a theoretical framework for this study, a combination was created of 
Pender’s Health Promotion Model (HPM) and Neuman’s System Model (NSM). The 
Neuman’s System Model provides the basis for understanding the essence of early 
TB case finding as a prevention strategy, while the Pender’s Health Promotion Model 
provides the framework for assessing the determinants associated with delays in TB 
case finding. Pender maintains that the determinants influencing an individual’s 
response to health action need to be assessed to assist health professionals in 
tailoring interventions to suit the specific clients/community needs (Peterson & 
Poredow, 2009:297-301). Neuman System Model emphasises that the 
client’s/communities is a holistic system that interacts with stressors and nursing 
action should identify these stressors and deliver appropriate prevention (Neuman, 
1995: 20-21; Neuman & Fawcett, 2002:16-21). 
2.4.1 Neuman’s system model 
 
The Neuman’s System Model is a wellness system-based model that focuses on the 
holistic nature of a client/community system and prevention as an intervention 
(Neuman & Fawcett, 2002:16-21; Neuman, 1995:20-21). The model addresses how 
the client’s variables (including, physiological, psychological, socio-cultural, spiritual 
and developmental) interact with internal and external stressors and how nursing 
prevention as intervention is applied to restore the clients to optimal wellness and 
stability (Neuman & Fawcett, 2002:16-17; Masters, 2005:42). This client-centred 
model describes the individual system as an open system comprising of a core 
(referred to as the person’s basic survival structure) and protective rings (which 
protects and restores the person to stability). The core consists of the person’s normal 
lines of defence (NLD) which helps the person to adapt to normal level of health. The 
surrounding protective rings consists of flexible lines of defence (FLD) and lines of 
resistance (LOR) which help to increase person’s resistance from stressor, decrease 
stressor reaction and return the individual/ community to stability and balance 
(Neuman, 1995: 20-21). Neuman and Fawcett (2002:21) describe a stressor as 
“tension-producing stimuli or forces occurring within the internal and external 
environmental boundaries of the client system”. It disrupts the individual or community 
causing physical illness, social or emotional crisis (Ume-Nwagbo, DeWan, Lowry, 
2006:32).  
The Nursing process was described in the Model as a “three-step format of nursing 
diagnosis, nursing goals, and nursing outcomes” (Neuman, 1996: 69). Neuman 
emphasises that the role of the nursing action is to assess the stressors (tuberculosis 
in this case) to the client/community, and reinforce the individual with adequate 
prevention which it classified in terms of primary, secondary and tertiary prevention. 
 2.4.1.1 Application of the Neuman’s System Model to TB case finding 
 
With reference to the model, tuberculosis disease is the potential stressor, when 
tuberculosis penetrates an individual or a community; it breaks the lines of resistance 
(LOR) and flexible lines of defence (FLD) and disrupts the person’s core, the basic 
survival determinants. The model emphasises that, of utmost importance, the flexible 
line of defence of a client/community need to be strengthened (against the stress) 
through promotion strategies carried out by nursing action so as to promote client 
wellness (Fawcett & Neuman, 2002). 
The primary and secondary prevention of the model apply to early TB case finding, 
the essence of this study.  
Primary prevention was described in the model as an intervention before a reaction 
occurs. Based on this, early TB case finding is a primary prevention strategy 
developed to maintain the wellness of the community by preventing them from getting 
TB infection (the stressor) from undiagnosed and untreated PTB patient with 
active/infectious TB disease (Neuman, 1995: 20-21; Ume-Nwagbo et al., CDC, 
2005:32). When TB cases are detected early, the rate of transmission of the infection 
to the community reduces. The reverse, delayed TB case finding, increases the 
number of people that get infected before an active TB case is diagnosed and treated, 
thereby perpetuating the burden of the TB epidemic (WORLD HEALTH 
ORGANIZATION, 2006a:6-12; Wood et al., 2010:113).  
The secondary prevention perspective of early TB case finding is directed to 
individuals already infected with the stressor, TB disease. The model implies that 
these individual should be assessed as early, to ensure prompt diagnosis and 
treatment to prevent the development of more extensive disease/ disease 
complication and possible death. 
2.4.2 Penders’ health promotion model 
 
The Pender’s Health Promotion Model (Pender, 1996) was an elaboration of the 
expectancy-value theory and the social cognitive theory. The HPM was developed for 
predicting health promotional behaviours, emphasizing the role of expectations in 
shaping of behaviours. It describes the multidimensional nature of individuals as they 
interact with the environment in pursuit of health. 
The model focuses on three major areas namely individual characteristics and 
experience; behaviour-specific cognitions and affect; and behavioural outcomes.  The 
HPM seek to understand the determinants of behaviours and postulates that three 
major groups of interrelated determinants affects individual’s commitment to plan of 
action which influences (directly or indirectly) the health promoting behaviours. These 
groups of influencing determinants includes (1) Individual characteristics and 
experiences (biological, psychological, personal, social and prior-related 
determinants); (2) behaviour-specific cognition and affect (perceived self-efficacy, 
perceived barrier to action, perceived benefits to action, activity-related affect, 
situational influences and interpersonal influences- such as from peer, family 
members, health providers, norms, supports, models); (3) immediate behaviour 
contingences (response to immediate competing demands and preferences) (Pender, 
Murdaugh & Parsons, 2006: 46-50). The model posits that these interrelated concepts 
can be modified through nursing actions. An understanding of the dynamics of these 
multidimensional and interrelated determinants provides insight to both health 
compromising and enhancing behaviours. The model structures a multistep process 
for health planning including reinforcing client strength; developing a plan based on 
client preferences; addressing barriers, facilitators and committing to goal. Health 
professionals are allowed to explore “the complex individual’s bio-psychosocial 
processes that motivate individuals to engage in actions directed towards 
enhancement of health” (Pender, et al., 2006: 47). “Measuring changes in these 
concepts is essential to determine if such changes influence the occurrence of health 
promotional behaviour” (Pender et al., 2006:52). 
The HPM assumptions are, that individuals seek to actively regulate their own 
behaviour; the individual in her bio-psychosocial complexity interact with the 
environment, progressively transforming the environment and being transformed over 
time; health professionals constitute a part of the interpersonal environment, which 
exerts influence on persons throughout their life span; self-initiated reconfiguration of 
person-environment interactive patterns is essential to behaviour change (Pender et 
al., 2006:63; Nursing Theories, 2012). The schematic framework (Figure 1) below 
depicts the major concepts comprising the Pender’s Health Promotion Model. 
 Figure 2.1: Schematic framework of the Health promotion model (Pender et al., 
2006:50) 
 
2.4.2.1 Application of the Pender’s Health Promotion model to this study 
 
 TB case finding is a strategy developed for improving the health status of people. 
Based on the concepts described in the model, TB case finding is taken as a health 
related action. The theory suggests that the multidimensional and interrelated 
constructs of the model could affect delayed TB case finding which in turn influences 
health promoting behaviour- the right behavioural outcome (Pender et al., 2006:45-
52). This Pender’s model-based assessment study will consist of a survey of patient’s 
personal determinants, perceived barriers to health seeking behaviours, perceived 
benefit of health seeking, perceived self-efficacy, activity related actions, interpersonal 
influences, situational influences, competing determinants and preferences that 
impact on delay TB case finding.  
Individual characteristics, a construct of the model, predicts that TB patients’ personal 
determinants such as socio-demographic determinants, clinical determinants, and 
their prior experiences with health providers or within their environments can possibly 
influence delayed detection of TB cases. Perceived Barriers refer to assessing 
patient’s identified barriers to seeking care. Distance/geographical barriers, poverty, 
cultural determinants, and stigma were proposed to influence early detection of TB 
cases. The construct of interpersonal influences predicts that influences from health 
system/health providers, family, peers, norms, can limit the chances of early detection 
of TB cases. Qualitative study on health worker’s perception of TB case detection 
found that staff attitude, staff workload, staff knowledge influence their delivery of TB 
services and thus delays in case finding (Woolf et al., 2006:68). Activity related effect 
refers to patient identified processes or activities that contribute to the delays in TB 
case finding, such as seeking care from non-specialized health providers, receiving a 
missed diagnosis at first health care consult, time interval between sputum submission 
and receipt of result (Woolf et al., 2006:67; Finnie et al., 2011:407). WORLD HEALTH 
ORGANIZATION (2006a:12) shows that delays in TB case finding in low TB prevalent 
countries were attributed mainly to the fact that TB is not suspected in patients seeking 
care (WORLD HEALTH ORGANIZATION, 2006a:12). Furthermore, the model posits 
that competing demands (referred to as alternative determinants) can interrupt early 
TB case finding. Mavhu, Dauya, Bandason, Munyati, Cowan, Hart, Corbett and 
Chikovore (2010:577) shows that TB patients are not detected early because they 
defer seeking care so as to prioritise their limited resources for more pressing family 
needs.  Lastly, the construct of preferences proposes that patient’s preferences to the 
type of health care to seek and choice of health provider to consult can influence 
delays in case finding. A systematic review on TB case finding studies shows that 
patient preferences for traditional/spiritual healers, pharmacists, over the counter 
outlets, etc, affect their chances of early case detection (Finnie et al., 2011:407). This 
study intends to assess these complex determinants in a resource-poor setting to offer 
professionals the opportunity to provide more appropriate interventions for the 
individuals and the community so as to achieve improved public health outcomes. 
 
 
 2.5 CONCLUSION 
 
It is evident from the literature reviewed that TB disease is a grave public health 
concern globally and even more so in South Africa where, due to the HIV pandemic, 
it has assumed epidemic proportions. Cacadu district (within which is the study setting 
of this research, Makana Municipality) has been reported to be particularly badly hit 
by the TB scourge, being the district with the second highest incidence rate of TB in 
South Africa in 2010. Efforts to control TB epidemic in South Africa has yielded limited 
results so far, partly because emphasis has not shifted to the case detection aspects 
of the TB control program. The WORLD HEALTH ORGANIZATION has advocated 
passive TB case finding as preferred over active TB case finding approach in high TB 
burden areas such as South Africa but unfortunately, delay in TB case finding 
continues to be extensively reported in both developing and developed countries. This 
delay in TB case finding has severe consequences for the TB sufferer as well as for 
the community to which he or she belongs.  
An understanding of the determinants that contribute to delay in TB case finding in 
particular settings can inform setting-specific interventions that enhance early 
detection of TB, and by extension, break the chain of transmission very early.  
To date, no study has attempted to explore a wide range of patients and health system 
related determinants that may contribute to delay in TB case finding in this 
municipality. This is what this study seeks to achieve. 
      
 
 
 
 
 
 
 CHAPTER 3 
RESESARCH DESIGN AND METHODS 
3.1 INTRODUCTION 
 
This chapter describes the overall plan for conducting the study, including the chosen 
study design, the sampling process, the population and selection criteria, the sample 
size, data collection and analysis. Also discussed in this chapter are the measures 
undertaken to enhance validity and reliability of the study as well as the ethical rigors 
followed in the study 
3.2 RESEARCH APPROACH 
  
The investigator followed a quantitative research approach. Burns & Grove (2009:717) 
defines a quantitative research as a “formal, objective, systematic study to describe 
and test relationships and to examine cause and effect interactions among variables”. 
Quantitative study follows a systematic approach and progresses from the definition 
of the problem, and relevant concepts to the solution of the problem (Polit & Beck, 
2008:16). It describes and measures phenomena that are quantifiable; and gathers 
empirical evidence that is rooted in objective reality. Brink, Van Der Walt, & Van 
Ransburg (2006:11) characterises quantitative research as the type of research that 
is concise and focuses on small number of concepts; it begins with pre-conceived 
ideas about how the research concepts are interrelated; uses formal instruments and 
structured procedures to collect information; emphasises objectivity in the data 
collection and analysis of information; analyses numeric information through statistical 
procedures; and the researcher takes an objective stance in the events under 
investigation.   
A quantitative research approach, therefore, was suitable for this study because of the 
following: 
 The study used the non-experimental/observational aspect of quantitative study to 
examine its phenomenon- delays in TB case finding and to describe its associated 
determinants in a given setting.  The study operationally defined the relevant concepts 
in measurable terms. A form of control was exercised in the study by the use of a clear 
definition of the study population and specified eligibility criteria for the respondents. 
Study samples, of a predetermined sample size, were also selected using probability 
sampling technique and the information from the respondents were captured using 
structured data collection technique with predesigned response set. The numerical 
data collected was analysed using descriptive and analytical statistics to enhance 
objectivity and provide statistical evidence to support the findings.  
3.3 RESEARCH DESIGN  
 
A research design is a structured approach that guides the planning and 
implementation of the study to achieve intended goal (Joubert & Ehrlich, 2007:77; Polit 
& Beck, 2008: 211). Burns & Grove (2009:696) described it as a plan for conducting 
the study that maximises control over determinants that could interfere with the validity 
of the findings. It is conceived and implemented with the purpose of bringing empirical 
evidence to a research problem. A non-experimental, descriptive, cross-sectional 
study design was used in the study.  
3.3.1 Descriptive research design 
 
According to Polit & Beck (2008:752), a descriptive research is research that its 
primary objective is to give accurate portrayal of the characteristics of phenomena of 
interest. In this study, the researcher sought to describe the determinants, situations 
and actions that were barriers to early identification of TB cases in a health district. 
This will arm health planners with accurate information that will guide TB control 
interventions in the community. 
3.3.2 Cross-sectional research design 
 
 Cross-sectional study design refers to a study design involving data collection at a 
given point in time (Barbie, 2011:82). The author refers to cross-sectional studies as 
studies that are designed to permit observation of a population or phenomenon at one 
point in time. In this study, the researcher conducted a survey of a population of PTB 
patients registered for treatment and collected data from them at one point in time. 
3.4 RESEARCH SETTING 
 
Research setting refers to the physical location and conditions in which the data 
collection process takes place (Polit & Beck, 2008: 766). 
As explained in section 1.8 of the study report, the study was conducted at the PHC 
clinics in Makana Municipality situated at the eastern part of Cacadu district in the 
Eastern Cape Province.  According to the latest census figures (Statistics South Africa, 
2012), as at 2011, Makana municipality had a population of 80, 390 with an average 
household size of 3.4 persons.  
3.5 RESEARCH METHOD  
3.5.1 Population 
 
Barbie (2011:91) describes the population for the study as the group about whom one 
wants to draw conclusions. A target population is defined as the entire set of elements- 
person, events or records that meet specified criteria and to which the investigator 
would like to generalise the research findings (Boswell & Cannon, 2011:146; Polit and 
Beck, 2008:767). The accessible population is that portion of the target population that 
conform to the designated criteria and whom the researcher can reasonably reach 
(Polit & Beck, 2008:339). Therefore, the target population in this study consists of all 
PTB patients in Makana Municiplaity and the accessible population was all PTB 
patients registered for treatment at those PHC clinics and actually available for the 
study.  
3.5.2 Eligibility criteria 
 
 Brink et al. (2006:124) defines eligibility criteria as the criteria used to select the 
respondents for the study. Boswell and Cannon (2011:149) describes eligibility criteria 
as characteristics necessary to be part of the research sample which are established 
to minimise systematic error or to control for irrelevant attributes in the sample. 
Inclusion criteria are those characteristics the respondents must have to enable them 
take part in the study while exclusion criteria are those attributes that if present in a 
respondents would make the person ineligible to be in the study sample (Boswell and 
cannon, 2011:149). 
In this study, the study sample includes only adult PTB patients, 18 years and older, 
who were started on treatment within nine months prior to the conduct of the study. 
The researcher excluded non-consenting patients; those who had been on treatment 
for over nine months because of greater chances of recall bias; medically unstable 
patients; and those with mental impairments because they may not be in the position 
to complete the questionnaire. 
 
3.5.3 Sample 
 
 A sample is a small part of a larger population that are selected for study (Williams, 
2011:184-185). The author emphasized that samples must be selected so that it is 
representative of the population to enable generalisation from the sample to the 
population. The sample for this study consists of the PTB patients who met the 
eligibility criteria. 
3.5.4 Sampling frame  
 
Sampling frame refers to the list of elements from which the sample for study are 
selected (Barbie, 2011:196).The sampling frame in this study was the list of PTB 
patients registered for treatment at the PHC clinics in Makana Municipality. Sampling 
frame was estimated as 531 PTB cases. This figure is 90% of the total TB cases on 
treatment as at the time of the study. This was informed by the report that 90% of all 
TB cases in Eastern Cape Province were Pulmonary TB cases (Day, Gray, & Budgell, 
2011:168) which also correlated with the information given by the Makana TB 
Coordinator (Data from TB Coordinator, Makana Municipality, 20/05/ 2012). 
   
3.5.5 Sampling and sampling procedure 
 
Sampling is the process or procedure of selecting units or individuals for observation 
Sampling is the selection of research respondents from the population so that 
inference can be made about the population (Barbie, 2011:176; Polit & Beck, 
2008:339). This study employed systematic random sampling in selection of study 
respondents.  
3.5.5.1 Probability/random sampling 
  
Probability/random sampling, according to Terre Blanche, Durrheim, and Painter 
(2006:139), is defined as a sampling approach that is determined by statistical 
principle of randomness. Joubert and Ehrlich (2007:95) describes probability sampling 
as a sampling technique that gives individuals in the population equal chance of being 
selected for the study so as to ensure representativeness of the study The researcher 
used this sampling approach to give the eligible patients equal chance of participating 
in the study to allow generalization from the sample to a larger population as 
emphasised by Barbie (2011:176). This sampling approach also helped the researcher 
to reduce the likelihood of systematic bias, thus, increasing the validity of the study. 
3.5.5.2 Systematic sampling  
 
Systematic sampling is defined as the selection of every n-th participant from the 
population list or sample frame (Barbie, 2011:201; Terre Blanche, Durrheim, & Painter, 
2006:135). This sampling technique was appropriate for the study because according 
to Polit and Beck (2008:348), systematic sampling can be applied where the 
population list is in strata. In this study, the sample was selected from individual lists 
for each PHC clinic.  Joubert and Ehrlich (2007:100) explained that a complete 
population list need not be known for a systematic random sampling to be applied. 
However, a particular order needs to be followed. In this study, respondents were 
selected in a particular order, from the list of those arriving for treatment. Furthermore, 
systematic sampling technique is convenient, less-laborious and can produce equally 
or more efficient result than simple random sampling (Terre Blanche, Durrheim, and 
Painter, 2006:135; Polit & Beck, 2008:347-348). 
3.5.5.3 Sampling procedure 
 
The researcher sought the assistance of the TB coordinator to obtain the list of PHC 
clinics in the Municipality from where five PHC clinics were systematically selected for 
study. The starting point (first PHC clinic) was randomly selected, and then every 
second PHC clinic was subsequently selected. Similarly, systematic sampling was 
used to select every third eligible PTB patient who attended the PHC clinic for 
treatment on the day of the research. The first patient was randomly selected from the 
list of those present and then every third patient starting from the first patient was 
subsequently selected until the desired sample size – from all the selected PHC clinics 
was reached. 
The table below shows research sample selected per PHC clinic. 
Table 3.1 Number of patients per chosen clinic 
PHC Clinic Population registered 
for TB treatment 
Study Sample 
Clinic A 52 13 
Clinic B 132 34 
Clinic C 151 39 
Clinic D 112 29 
Clinic E 84 22 
 
3.5.6 Sample size   
 
Brink et al., (2006:135) defined sample size as the total number of respondents who 
will take part in the study. Many determinants affect the choice of sample size; 
however, practical factor such as cost and convenience prove most influential in 
sample size determination (Boswell & Cannon, 2011:155-157). Larger sample sizes 
are required for quantitative studies, studies with heterogeneous population and 
complex studies. Polit and Beck (2008:348) notes that there is no specified formula 
for determination of sample size, the largest sample size being more desirable. The 
sample size is a function of level of precision and possible variations in the attributes 
present in the population (Joubert & Ehrlich, 2007:346-347).  
The sample size for this study was calculated using Cochran formula (1963:75): no = 
(Z2pq/e2). Where Z is the abscissa of the normal curve that cuts off an area at the 
tails,- set at 1.96 at 95% desired confidence level; e is the desired level of precision, 
set at 0.05; p is the estimated proportion of an attribute that is present in the population, 
this was taken as 9%  based on similar study conducted in a high TB incident setting 
in Peruvian Amazon (Ford, Bayer, Gilman, Onifade, Acosta, Cabrera, Vidal & Evans, 
2009:1099-1100); and q is (1-p) = (1-0.09) = 0.91.  
no = {[1.962 (.09 x .91)]/ (0.052)} = 125.851 
An adjustment of this sample size for a small population was performed using an 
adaptation from Cochran formula, n= no/ [1+ { (no-1)/N}] (Glenn, 2009:3) 
Where, N is a population of 531 PTB patients registered for treatment at the PHC 
clinics in Makana Municipality (Data from TB Coordinator, Makana Municipality, 20/05/ 
2012).  
n= 126/ [1+ {(126-1)/531}] = 102 
Therefore, the sample size, n, appropriate for this study was 102 respondents. The 
appropriateness of this sample size was confirmed with the statistician.  However, a 
total of 137 respondents were approached for inclusion in the study so as to 
accommodate non-response and incomplete data. 
3.6 DATA COLLECTION 
 
Data collection is described as the objective, systematic and organised gathering of 
information necessary to achieve the objectives of the study and to enable 
generalization of the outcome of the study from the study sample to broader population 
(Burns & Grove, 2009:695; Boswell & Canon, 2011:218). The information gathered in 
the study is referred to as data (Burns & Grove, 2009:695).  
   
3.6.1 Data collection process 
 
The data was collected using structured questionnaire. The researcher obtained 
permission to conduct the study from the Eastern Cape Provincial Department of 
Health, the Manager in charge of all the clinics at Makana Municipality Local Service 
Area and the responsible managers of the different PHC clinics (see annexure). The 
managers of the respective clinics identified suitable private area within the premise 
for the interview session; however the respondents had the option to choose the place 
for the interview.  The list of the clinics along with the registered TB cases in each 
clinic was obtained from the TB coordinator, from where the respondents were 
recruited in the study. 
The data was collected over a period of one month. The researcher and trained 
research assistants were visiting the clinics during the morning hours to synchronise 
with the morning hours scheduled for TB patients arriving at the clinics for treatment. 
The interviewer and research assistants distributed the self-administered 
questionnaire (SAQ) in-person to the research respondents after the purpose of the 
research and the respondents’ ethical rights had been explained to the respondents. 
Written informed consent was also obtained before data collection instrument was 
given to individual respondents. Structured face-to-face interview was used for 
respondents who could not complete the questionnaire by themselves. Joubert and 
Ehrlich (2007:107) stressed that in using SAQ, the questions may be read out to the 
respondents and answers filled in by the respondents in a structured manner. 
Questionnaire distributed in-person to the respondents increase their response rate 
(Polit & Beck, 2008:430). The questionnaire was completed by the respondents in a 
private room within the study setting and at respondents’ time of convenience. On 
each data collection day, the researcher was available to answer and clarify any 
questions the respondents may have and to ensure that there was no interference that 
might influence data collection 
3.6.2 Data collection instrument and development 
 
This section discussed the process followed to develop the data collection 
instruments. 
3.6.2.1 Questionnaire as data collection instrument 
 
The researcher used self administered questionnaire for data collection instrument. A 
data collection instrument is the physical device employed to collect information in a 
study (Boswell & Canon, 2011:218). A questionnaire is a formal written document used 
to solicit information for analysis (Barbie, 2011:515; Polit & Beck, 2008:372). A 
questionnaire was an appropriate data collection instrument for this study because it 
had been described as an efficient instrument well suited for descriptive studies. This 
is because its main features (being those of impersonality and fixed questions) ensure 
that the researcher does not influence the responses from the respondents and does 
not change the questions according to how the responses develop (Williams, 
2011:190). A questionnaire is cost-effective, less time consuming, allows anonymous 
collection of data, and the data collected is easier to analyse as respondents respond 
to the same questions (Wood & Ross-Kerr, 2011:125; Joubert & Ehrlich, 2007:182; 
Polit & Beck, 2008:423-424). In this study the questionnaire was well-structured to 
obtain detailed information from the respondents; the questions were simple, clear and 
concise and made it easier for the respondents to complete. Response rate was also 
increased as the questionnaire demanded less of the respondent’s time and literacy 
skills (Stommel and Wills, 2004:246).  
3.6.3.2. Structured data collection 
 
Polit and Beck (2008:767) describes structured data collection as a data collection 
approach in which the response categories are specified in advance. According to 
Stommel and Wills (2004: 245), structured data collection entails predetermined 
questioning of the respondents and the responses are made from fixed response 
option. In this study, the researcher developed the questionnaire before-hand. The 
wordings were predetermined and the possible response options were recorded from 
which the respondents selected the responses applicable to them. Polit and Beck 
(2008:414-413, 371-372) stated that a mixture of closed- and open-ended question 
helps to offset the weaknesses of each in a questionnaire. In this study, the choice of 
closed-ended question helped to reduce the writing burden on the TB patients, 
accommodated those respondents that may not express themselves properly. It 
increased the response rate as most respondents completed the questionnaire. The 
researcher also experienced ease of quantification of the data collected in the study. 
Open-ended questions, on the other hand, helped to accommodate potentially 
important response the investigator may have overlooked and reduce the bias of 
respondents’ choice of options that misrepresent their position. 
3.6.2.3. Development of the data collection instrument 
 
The questionnaire was compiled based on knowledge obtained from the review of 
current, peer reviewed. While a vast body of  TB literature was reviewed in the course 
of developing the study questionnaire, greater insight and guidance was provided by 
the studies conducted by Finnie et al (2011: 396-406) and  Meintjes et al. (2008:3-6) 
as well as some sections of the questionnaire of the WORLD HEALTH 
ORGANIZATION (2006:42-45) study on TB diagnostic and treatment delay.  The draft 
questionnaire was reviewed by a family physician who had extensive theoretical 
knowledge of and experience in the diagnosis and management of TB patients in 
primary health care settings. His critical input was used to improve on the draft 
questionnaire while the findings of the pilot study were used to develop the final version 
of the questionnaire. The questionnaire was used to collect data on such variables as; 
socio-demographic information of the patient- age, sex, employment status, level of 
education, income; access to health facility; knowledge about TB; health seeking 
behaviour; time of onset of symptom; time taken to seek care; type of care sought; 
time of first presentation to a health care facility on TB related symptoms; number of 
visits made prior to diagnosis. This information was used to establish the determinants 
contributing to delays in TB case finding. Information obtained was also used to 
estimate proxies for patient delay (time duration from onset of symptom to the time of 
first visit to a health care facility) and health system delay (the time from first visit to a 
health care facility to the time of eventual diagnosis) in line with the previous studies 
(Storla et al.., 2008: 4-8). 
The questionnaire was developed in both English and Isi-Xhosa language. The 
translations from English to isi-Xhosa and back-transcription were done by 
professional transcribes (Annexure F& G). 
 
3.7. DATA ANALYSIS 
 
According to Polit & Beck (2008:751), data analysis is the systematic organisation and 
synthesis of data gathered in the study and the testing of hypothesis using the data in 
case of quantitative study. It is performed to reduce, organise and give meaning to the 
data collected in the study (Burns & Grove, 2009:695).  
The data captured from the eligible PTB patients was cleaned and double entered 
using EPI info computer software and the two data checked for discrepancies. 
Randomly, the data entered was checked against the actual data on the data collection 
forms.  
Statistical analysis was performed using Statistical Package for Social Sciences 
(SPSS version 19.0). Each variable collected was described in relation to delays in TB 
case finding. Quantitative data obtained were summarised and associations explored 
using descriptive and inferential statistics (Joubert & Ehrlich, 2007:135-136). The 
sample population was described using descriptive statistics, in the form of 
frequencies, contingency tables, mean, range and percentages of age, gender, level 
of education, employment status, and marital status. The duration of the dependent 
variable (delay TB case finding) was calculated in terms of mean and median days. 
Statistical significance of variables was estimated using bivariate tests (fisher’s exact, 
student t test and Chi-square tests) as appropriate. The suitability of the suggested 
analysis was discussed with a statistician. 
3.8. VALIDITY AND RELIABILITY 
 
Validity and reliability are important criteria for assessing the quality of a study (Polit & 
Beck, 2008:196). Barbie (2011:131-133) defines validity as the extent to which a 
measure or an instrument accurately measures the concepts it is supposed to 
measure. Joubert and Ehrlich (2007: 160) asserted that a valid study is one that 
represents the truth, and has minimised systematic errors in the way samples are 
selected and the way data is collected (selection bias and information bias). 
Representativeness of sample and external validity of the findings are of utmost 
importance in descriptive studies (Terre Blanche et al., 2006:91). 
3.8.1 Validity of the data collection instrument 
 
 The questionnaire was pilot-tested on 10 respondents other than the study participant 
to determine the appropriateness of the question.  
3.8.1.1 Pretesting of the instrument 
 
A pilot study is described as the pre-testing of the data collection instrument on a small 
number of people who are similar to the intended study sample so as to test the 
procedure and quality of responses and rectify any source of confusion or any problem 
of comprehension (Williams, 2011:190-191. 365) After the approval of the 
questionnaire, the questionnaire was given to a qualified family physician who is an 
expert in infectious diseases especially TB. His inputs gave guidance on the 
appropriateness, clarity, sequence and length of the questions, and the questionnaire 
was adjusted as recommended. The questionnaire was then pre-tested on 10 
respondents selected from one PHC clinic in a near-by municipality (Ndlambe 
Municipality) within the same Cacadu district. From the list of the patients arriving to 
the PHC clinic for treatment, the first patient was randomly selected and then every 
third patient was subsequently selected to make the sample for the pilot study. The 
respondents were of similar population as the study population and they met the 
eligibility criteria specified for the main study. However, respondents who took part in 
the pilot study were not included in the main study. 
The respondents’ reactions/difficulties, common responses and other logistical 
information were recorded and used to modify the final questionnaire. Few flaws and 
irregularity in the sequence of the question; ambiguity in the concept and language of 
the questions were identified and corrected in the final version of the questionnaire. 
The pretesting of the instrument enabled the estimation of the time duration required 
for the completion of the questionnaire Identified problems were used to adjust the 
questionnaire before it was administered to the research respondents. The 
questionnaire was transcribed, using professional transcribers, to isi-Xhosa (the 
dominant local language in the study setting) and a different language expert 
transcribed the Xhosa version to English to ensure validity of the questionnaire. In 
addition, the probability sampling used for sample selection helped to minimise 
random sampling error. 
3.8.2 Internal validity 
 
Internal validity of a study can be enhanced through judicious design decisions and 
minimising possible measurement and sampling biases (Polit & Beck, 2008:295-307). 
For this study, the study was conducted in the respondents’ natural environment- the 
PHC clinics; the sampling technique was predetermined and adhered to. Probability 
sampling was used to ensure equal chance of selection and representativeness of the 
population of interest. 
According to Joubert and Ehrlich (2007:163), the data collected from the respondents 
is expected to be unbiased and representative of the population’s views. Therefore, 
data was collected at a private place and at the participant’s convenience to ensure 
an unbiased response. Information bias was noted as a common occurrence in self-
report (Joubert & Ehrlich, 2007:163), as the study respondents may decide to 
compromise their responses on issues they are not comfortable with. Owing to this, 
the respondents were recruited and explained the importance of the study and assured 
of anonymity of their response. Unlinked anonymous written questionnaire was used 
for data collection in cases where respondents did not need assistance with reading 
and/or understanding the relevant version of the questionnaire. A question in the data 
collection instrument was aimed at determining if the respondents have been resident 
in the municipality from, at least, at the onset of TB symptom to diagnosis. This is 
intended to ensure that the information obtained pertains to the municipality. Double 
entry of data and cross-checking of discrepancies was used to reduce measurement 
bias. Appropriate statistical analysis was also used for data analysis with the help of a 
statistician. 
   
3.8.3 External validity 
 
 External validity is defined as the degree to which the outcome of the study can be 
applicable to other populations, programs and settings other than the study sample 
(Burns & Grove, 2009: 700; Fink, 2008:336-337). It is anticipated that the outcome of 
this study will only be generalizable to the Makana Municipality. 
3.8.4 Reliability 
 
 Terre Blanche, Durrheim, and Painter (2006:92-93) define reliability as the degree to 
which a research result can be reproduced on replication of the study. Mitchell and 
Jolley (2013: 161-164) explains reliability as the relative absence of random error 
(unsystematic selection and measurement errors). It is the consistency of the measure 
obtained from using a given instrument (Burns & Grove, 2009:719)  
To ensure reliability of the data collection instrument, the supervisor’s assistance was 
sought throughout the development of the questionnaire to ensure a reliable 
instrument. The questionnaire was developed based on sound knowledge obtained 
from extensive review of current TB research literature. Reports of previous published 
studies as well of adaptation of sections of the WORLD HEALTH ORGANIZATION 
study questionnaire all guided the development of the questions contained in the 
questionnaire. Critical insight provided by the medical expert also further enhanced 
the reliability of the data collection instrument. 
3.9 ETHICAL CONSIDERATIONS 
 
Ethics is defined as a system of moral value which measures the extent a given study 
abides by the legal, social and professional rules (Polit & Beck, 2008:753). It deals 
with issues of human conduct that are relevant to a particular profession (Pera and 
Van Tonder, 2005:4). Houser (2008:66) describes ethics as the rights and wrongs in 
the conduct of a research. An ethical study entails a good demonstration of the integrity 
of the research process; protecting the welfare and ensuring dignity of the respondents 
including the welfare of those whom the outcome of the study may affect (Terre 
Blanche et al., 2006:61; Houser, 2008:66). 
The ethical rigors for this study are discussed as thus: 
3.9.1 Protecting the right of the respondents 
 
Beneficence: No physical harm was anticipated in this study, however, the researcher 
endeavoured to minimise risk and maximise benefit that the research generated. The 
researcher did not interfere in the respondents’ treatment hours. The interview session 
was conducted at the shortest possible time, to minimise any wastage of respondents’ 
time. As was stressed by Polit and Beck (2008:170), the interview with any participant 
was terminated as soon as the researcher suspected that continuing would have 
caused undue distress to the respondents. The questions were structured in such a 
way as to avoid any allusion to anything that might intrude on the respondents’ 
psyches. The study may not benefit the respondents directly, but they would have had 
better knowledge of the topic in question by participation in the study. The study 
findings, which were shared with the Makana Municipality, might enable the Makana 
Municipal TB control authorities to plan adequately for strategies for optimising early 
detection of TB cases which will ultimately benefit the TB patients. 
Respect of respondents: (Informed consent, self-determinism, transparency and 
autonomy). According to the National Health Act 61 of 2003, research respondents 
will be human respondents who are legally and mentally competent to participate in 
study (Joubert & Ehrlich, 2007:3). The study included stable PTB patients, aged 18 
year and older, who were also mentally competent to autonomously participate in the 
study. The respondents were given clear, simple and detailed information about the 
study, so that they could understand and have the power to decide on participation in 
the study. The risk and benefit of the study were shared with the respondents so that 
they could decide if the study was worth their participation. They were requested to, 
on voluntary basis, give a written consent to participate in the study and a copy of the 
signed consent form was retained by the respondents. The investigator also informed 
them that they had the freedom to ask question, refuse or withdraw from the study at 
any time of their choice, without proffering any reasons for the withdrawal and without 
suffering any compromise to their health benefits. 
Anonymity: Anonymity was ensured by distributing unlinked anonymous 
questionnaire to respondents, who were requested not to indicate any identifying 
information on them. 
Confidentiality: Confidentiality of participant and their information was maintained 
throughout the study. Because the questionnaire was distributed in-person, anonymity 
was fully ensured by giving the respondents a promise of confidentiality that the 
information they provided will not be shared with people known to them or reported in 
a manner that identifies them. Neither the researcher nor any of the three research 
assistants had been involved with health management of the patients. Data was 
collected at a private place and patients were not coerced into sharing private 
information. Responses from respondents were kept private, in a locked file, and those 
entered into the computer system were password-protected. 
Justice: The respondents were treated with equity, fairness and respect during all 
stages of the study. The selection of the respondents was based on the requirement 
of the study and not on the compromised position of any person, or selective selection 
of those with special qualities. The researcher/research assistants were polite and 
gracious and ensured that the respondents were not exploited merely because they 
were accessible to the researcher. Justice required that the researcher had some 
responsibility to provide care and support for respondents who may become 
distressed or harmed by the study (Terre Blanche, Durrheim, and Painter, 
2006:68).The study caused no harm except the time it took the participant to complete 
the questionnaire. 
 Researcher- participant relationship: As proposed by Polit and Beck (2008:171-
172), the respondents were neither coerced into the study nor exploited. They were 
given detailed information sheet (in isi-Xhosa or English language) and only gave 
written informed consent after all their queries regarding the research had been 
addressed. During the process they were trained against ‘Halo effect’ (Murphy, Jako, 
& Antialt, 1993:220)- they were trained to feel that they were not  ‘constrained’ by their 
previous experiences of the health facilities and should feel able to give right 
judgements. Respondents were informed that their participation or the information they 
provided will not be used against them. Being a quantitative study, the investigator 
took an objective stance, to simply avoid doing harm. 
3.9.2. Protecting the right of the institution 
 
 In accordance with the South African Health Act (Act 61 of 2003) (Terre Blanche, 
Durrheim &Painter, 2006:61), prior to the commencement of the data collection, 
written approvals of the protocol of this study were secured from the Higher Degrees 
Committee of Health Studies Department, University of South Africa (UNISA), the 
Eastern Cape Department of Health Research and Ethics Committee and the Makana 
Municipality Health Authority. 
3.9.3. Scientific integrity of the research 
 
The study purpose, to investigate determinants influencing delay in TB case finding, 
is scientifically significant and did not place respondents at unnecessary risk. The 
methodology and data analysis procedure was rigorous, justifiable and feasible and 
led to valid results (Terre Blanche, Durrheim, and Painter, 2006: 70). The research 
protocol developed for this study by the researcher and the design processes was 
adhered-to. All the analyses decisions were made prior to data collection to minimise 
any manipulation of data. The researcher’s integrity and moral probity was also 
brought to bear on the research process as data collected were honestly handled, 
analysed and truthfully reported while the research protocol was scrupulously adhered 
to. Exhaustive literature review was conducted with due acknowledgement of sources 
consulted. 
3.10 CONCLUSION 
 
This chapter discussed the research design used in the study and methodology 
employed. The researcher conducted a quantitative, non-experimental, descriptive 
study to investigate the determinants associated with delays in TB case finding. 
Information was collected from the respondents using structured questionnaire. 
 
. 
  
            CHAPTER 4 
PRESENTATION OF RESULTS 
4.1 INTRODUCTION 
  
The previous chapter (chapter three) dwelt on research design and methodology. A 
quantitative, non-experimental descriptive study design was used to investigate the 
research objectives. This chapter (chapter four) deals with data analysis and 
presentation of the main findings of the result. 
 The objectives of this study were  
- To assess the time duration of delay in TB case finding among PTB patients in 
Makana Municipality 
- To identify patient-related determinants contributing to delays in TB case finding 
among PTB patients registered for treatment in Makana Municipality. 
- To identify the health system-related determinants contributing to delays in TB 
case finding among PTB patients registered for treatment in Makana local 
Municipality. 
4.2 DATA ANALYSIS 
 
Data analysis (in consultation with a statistician) was performed using Statistical 
Package for Social Sciences (SPSS version 19.0). Each variable collected was 
described in relation to duration of delay in TB case finding. The data collected was 
analysed using descriptive statistics, in the form of frequencies, contingency tables, 
mean, range and percentages to summarise the variables including age, gender, 
employment status, marital status. The duration of the dependent variable (delay TB 
case finding) was calculated in terms of mean and median days. Comparisons 
between groups were made using Chi-square test or Fischer’s exact test as 
appropriate for categorical variables. Level of significant was determined at 95% (p 
value = 0.05). All tests were 2-sided.  
4.3 PROFILE OF THE PULMONARY TUBERCULOSIS PATIENTS 
 
This section dealt with the participant’s socio-demographic characteristics including 
gender, age, marital status, highest education attained, marital status, financial status, 
crowding index (this is a term used in this study to refer to a measure of the number 
of individuals living in the same house as the research participant)  
 4.3.1 Demographic information  
 
A total of 137 eligible PTB patients were included in the study. Only three respondents 
were unwilling to participate in the study, providing a response rate of 98%. 
4.3.1.1 Gender 
 
Figure 4.1 shows that among the PTB patients interviewed, there were more males 
(55.2%, n=74) than females (44.8%, n=60). 
  
Figure 4.1: Distribution of Pulmonary TB patients in Makana Municipality by gender 
4.3.1.2 Age 
The ages of the respondents range from 20 to 68 years with a mean age of 38 years 
(standard deviation = ±10.4). The majority of the respondents (71.4%, n=95) were 
within the ages of 25- 45years. Respondents less than 25 years old were 9% (n=12) 
of the study population while 6.8% (n=9) of the patients were older than 55 years old. 
Figure 4.2 below show the distribution of the PTB patients by age 
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 Figure 4.2 Age distribution of Pulmonary TB patients in Makana Municipality 
 
4.3.1.3 Number of people living in the same households 
 
37% (n=49) reported they had three people or less living in the same house and 63.4% 
(n=85) had four people or more living in the same house. 
 
4.3.1.4 Marital status 
 
Of the respondents, 14% indicated they were married, 9% were divorced/ separated, 
5.2% were widowed, 14.9% were cohabiting with their partners and 63.4% were 
single. 
4.3.1.5 Educational status 
 
Table 4.1: Respondents’ educational status 
Highest education level Frequency Percentage 
No formal education 3 2.2 
Grade 1-6 26 19.4 
Grade 7-12 102 76.1 
Any higher education 3 2.2 
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Table 4.1 above shows that the majority (76.1%, n=102) of PTB patients are scholars 
in secondary/high school. And very few (2.2%, n=3) of the PTB patients had either no 
formal education or a form of tertiary education in each case. 
4.3.1.6 Employment status 
 
The employment status was grouped into unemployed, employed, grant/pensioned 
and others. The distribution of the respondents by employment status is depicted in 
figure 4.3 below 
 
Figure 4.3: Employment status of the respondents 
 
NB: The category “Others” above include casual workers and student.  
Figure 4.3 above shows that more than two-thirds (64.2%) of the PTB patients were 
either unemployed or depended on the government for their livelihood either through 
social grants or pension 
4.3.1.7 Financial status 
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Only a small proportion of the respondents (4.4%, n=6), have savings usually while 
47.0% (n=63) admitted that their income just about covers all their expenses most of 
the times. Almost a quarter (21.7%, n=21) were dependent on others for all their 
financial needs while 32.8% (n=44) were normally in debt. 
The socio-demographic characteristics are significantly associated with delay of any 
type were gender, financial status and crowding index. Gender was significantly 
associated with patient delay. Males tended to experience more delay than females.  
Financial status, on its own, was significantly associated with health system delay, 
with the more affluent respondents (whose incomes normally match or exceed their 
expenses) tending to have less delay.  It is important to note that marital status, 
educational level, age and employment status were not included in table 5.0 because 
they were not found to be significantly associated with any type of delay. 
4.3.2 Personal habits 
 
Personal habits asked the respondents about their smoking habits and exposure to 
cigarette smoke by staying with a person who is smoking. 
4.3.2.1 Smoking history 
 
About half (50.7%, n=68) of the respondents had never smoked cigarette in their life 
while a similar proportion (49.3%, n=66) were either currently smoking or had smoked 
in the past. 61.9% (n=83) reported they were passive smokers (had someone close to 
them who smoke).See table 4.2 below for the details. 
Table 4.2 distribution of patients by smoking history 
Smoke cigarette  
Never 
Currently 
Quitted 
 
68(50.7) 
34 
32 
Passive smoking 81 
 
Passive smoking (living with someone who smokes) was associated with longer delay 
for both patient and health system delay. However, among the 34 respondents that 
were still smoking, there was no statistically significant association between current 
smoking status and patient or health system delay (p value 0.894). Similarly, analyses 
of the duration of smoking (for both current and former smokers) showed no 
statistically significant association with delay (both patient and health system related) 
in TB case finding (p value 0.478) 
 
4.3.3 Patient’s characteristics 
 
Just over a quarter of the respondents (27%, n=36) had previously had TB while 3.7% 
(n=5) of all the respondents had drug resistant TB cases. A prior medical history of 
other lung diseases before the current TB disease was reported by 3.7% (n=5) of the 
respondents while 17% (n= 23) patients were admitted in a hospital as at the time of 
TB diagnosis. 
4.3.4 Symptoms experienced 
 
Table 4.3 below shows the distribution of various symptoms experienced by the 
respondents. Cough and febrile illness were the main first symptoms experienced by 
the respondents. Likewise, the two most frequently cited symptoms experienced , at 
any time during the course of the illness up to the study time  were constitutional 
symptoms ( this are symptoms like weight loss, fatigue, loss of appetite, etc that show 
affectation of many different systems in the body) and febrile illness. 
Table 4.3: Distribution of symptom experienced and presented to health care 
provider 
Symptoms experienced and presented Frequency n(%) 
First symptom experienced * (missing data *) 
Cough 
Febrile illness 
Chest pain 
Difficulty in breathing 
Coughing-blood 
Constitutional illness 
 
70(52.6) 
40(30.1) 
9(6.8) 
6(4.5) 
2(1.5) 
6(4.5) 
Other symptoms experience during the course of the 
illness 
Cough >2weeks 
Febrile illness  
Chest pain 
Difficulty in breathing 
Constitutional illness 
 
34(25.0) 
77(57.5) 
26 (19.4) 
19(14.2) 
79(59.1) 
Symptoms presented to health provider 
Cough> 2weeks 
Chest pain 
Difficulty in breathing 
Coughing-blood 
Febrile illness  
Constitutional illness 
 
101(75.4) 
35(26.1) 
37(27.1) 
 
113(84.3) 
118(88.1) 
 
Cough, as the first symptom experienced, was associated with more patient delay but 
was not significantly associated with health system delay. Conversely, however, 
coughing up blood was associated with less patient delay, probably as a consequence 
of fright at the sight of blood in the sputum which may have prompted the patients to 
seek care earlier. On the other hand, as a first symptom, associated with more health 
system delay was difficulty with breathing. Possible reasons for this may have been 
an initial misdiagnosis of TB as asthma or bronchitis or other lung diseases that 
present with difficulty with breathing. Having febrile illness as the first symptom was 
associated with shorter health system delay. 
 
4.3.5 Types of care sought 
 
Table 4.4 below show that all (100% of) the patients were diagnosed with TB at a 
government health facility (clinic or hospital) despite 54.5% of the respondents initially 
visiting the pharmacy store or traditional healer/spiritual healer at the onset of TB 
related symptoms.  Additionally, there is a tendency for the patients to visit multiple 
categories of care before TB diagnosis as shown by the significant proportion (43.8%) 
of the respondents that visited two or more categories of care provider before 
diagnosis. When asked about first action taken when they first experienced TB-related 
symptoms, 44.8% (n=60) consulted government health facility first while some others 
(53.2%, n=74) initially took other actions including taking oral herb, visiting traditional 
healer, spiritual healer, pharmacy shop and private health facility. The table also 
shows that private doctors are rarely presented to with TB symptoms as only 2.2% 
(n=3) visited private health facility before eventually going to government health 
facility. 
Table 4.4 Health facility where TB was diagnosed 
Variable Frequency
Health facility of TB diagnosis 
Government clinic/hospital 
 
134(100) 
 
This section further dealt with the reason why the respondents did not seek care during 
the onset of TB-related symptom. When asked if they sought care immediately they 
had TB related symptom, only 32.8% (n=44) reported they sought care at the onset of 
TB-related symptom. Table 4.5 below depicts the reason given by the respondents 
that waited before seeking care. The table shows that the commonest reason (57% of 
the time) given by patients for not seeking help early was the expectation that they 
would get better. This is probably due to the assumption (noted in table 4.3 above) by 
majority of the respondents that TB symptoms were those related to ‘flu. Significantly, 
lack of money and the fear of being diagnosed with TB or of HIV featured as important 
reasons for not seeking care immediately. 
Table 4.5: Reason for delay before seeking help after onset of TB related symptom  
Reason for not seeking care during onset of TB-related symptom Frequency (%) 
Thought I will get better 57 
Fear of TB diagnosis 26 
Fear of TB stigma 13 
No money 29 
Fear of compulsory HIV test 23 
No reason 23 
Busy 14 
 
Table 4.6 Health seeking behaviour prior to TB diagnosis 
Variable Frequency (%) 
What did you think was wrong with you 
Thought TB   
Thought HIV 
Other medical condition 
Cold or flu 
Bewitched 
Psychological problem 
Don’t know 
 
67 (50.0) 
43 (32.1) 
14 (10.4) 
97(72.4) 
6(4.5) 
14(10.4) 
29(21.6) 
First health visit 
Government health facility 
Traditional/spiritual/pharmacy/private 
             Private 
             Pharmacy shop 
             Traditional/spiritual healer 
 
60(44.8) 
73(54.5) 
3(2.2) 
36(26.9) 
35(26.1) 
Common pattern of consultation 
Government sector only 
Pharmacy shop, Private GP and government sector only 
Pharmacy shop and government sector only 
Traditional/spiritual healer, pharmacy shop, government 
sector only 
Traditional/spiritual healer and government sector only 
 
60(44.8) 
3(2.2) 
36 
21 
14 
No of different types of care sought before TB 
diagnosis  
Only one type 
Two types 
More than two types 
 
60(44.8) 
43(30.1) 
31(23.1) 
 
Actions that took place during initial visits to health facilities 
The table 4.7 below shows that the commonest action that took place at the first visit 
was taking sputum samples (n=114) while taking a chest x-ray was the second 
commonest initial action taken. 
Table 4.7: Action that took place during the initial visits to the hospital 
 Frequency (%) 
I did not tell all the symptoms I experienced 
I was given antibiotics 
I gave sputum 
Had two positive sputum 
Sent for chest X-Ray 
13 
5 
114 
7 
53 
 
Sputum turn around- Among the respondents who were asked to give sputum during 
their visits, only 20.1% (n=12) received their TB result within two days while 79.9% 
(n=107) received their result after two days. When asked about the reason for 
receiving their results after two days, majority of the patients (79.1%, n=106) said the 
date they were given to come for their result was more than 2 days. 11.2% (n=15) said 
they did not go back to the health facility early after sputum was collected.  
The study found that shorter patient delay was associated with visiting a government 
health facility first while longer patient delays were associated with visiting the 
traditional /spiritual healer and pharmacy shops.  Longer health system delay, on its 
own, was associated with seeking multiple types of care and the “pattern” of care 
sought (“pattern of care” in this study relates to the order in which the different types 
of care providers were visited). 
4.3.6 Role of health system in raising awareness in TB 
 
The table 4.8 shows that awareness of TB was high among the respondents with a 
high proportion of them (87%, n=116) having heard of the disease, TB, prior to the 
onset of their symptoms. Likewise, the study found that a very high percentage of the 
PTB patients had fairly good knowledge concerning TB with more than 95% correctly 
stating that TB was curable and infectious. However a smaller percentage (58%, n= 
79) correctly identified the infectious organism as “bacteria”. Despite the high TB 
awareness prior to onset of TB symptoms and the fairly good knowledge, the table 
above however showed that only half (n=67) of the patients rightly suspected that 
symptoms were indeed those of TB. And almost three quarters (72%, n=97) initially 
mistook their symptoms to be due to ‘flu (upper respiratory infection). Significantly, 
almost 70% of the respondents believed that TB is hereditary. 
Table 4.8 TB awareness 
 
Variable Frequency (%) 
TB Awareness 
Heard about TB before onset of illness 
                      Yes 
                      No 
 
 
116(86.6) 
18(13.40) 
Knowledge/perception about TB 
Caused by evil spirit 
TB is hereditary 
Curable 
Infectious 
Caused by bacteria 
Male should take responsible of their illness 
 
38(28.4) 
93(69.4) 
132(98.5) 
129(96.3) 
79(58.0) 
48(35.8) 
  
Regarding the source of health information about TB, 69% (n=93) got their information 
from friends, 71% (n=95) got theirs from the media while a much smaller proportions 
heard about TB from either a health worker (38.1%, n=51) or at a health talk (24.6%, 
n=33).  
 
4.3.7 TB and stigma 
 
Table 4.9 highlights the information elicited from the respondents about stigma. On 
the stigma level, only a very small minority of the respondents (1.5%, n= 2) reported 
they had no form of stigma, 68.7% (n=92) had some degree of stigma and 29.9% 
(n=40) were highly stigmatised. In this study, “highly stigmatised” means answering 
“yes” to more than four of the nine questions posed regarding stigma while “some 
degree of stigma” means answering “yes” to between one and four stigma-related 
questions on the questionnaire. This study thus suggests that TB is still very much a 
disease that its patients perceive to be stigmatizing. Indeed about a third (34%, n=45) 
reported that visiting the TB clinic in the health facilities is associated with stigma 
 
Table 4.9: Stigma about TB 
Variables Frequency 
(%) 
Feel ashamed they had TB and will not want people to know they 
have TB 
TB affect relationship / will not want to associate with people who 
had TB 
There is stigma with visiting TB clinic 
Everyone who has TB also has HIV 
Chance of girls who has TB getting married is limited 
TB affect work performance 
70(52.2) 
58(43.3) 
45(33.6) 
29(21.6) 
48(35.8) 
92(68.7) 
Stigma level 
No stigma 
Some degree of stigma (≤ median) 
Highly stigmatised(>median) 
 
2(1.5) 
92(68.7) 
40(29.9) 
 
The study found that stigma was associated with longer duration of both patient and 
health system delay. Patients who felt that being seen at the TB clinic was stigmatising 
tended to have more delay. Those that believed TB had “some stigma” associated 
with it had less patient delay compared to those who felt TB was “highly stigmatising”. 
Also, patients who felt ashamed of having TB and did not want people to know that 
they had TB were associated with more health system delay. 
 
4.3.8 Access to health facility 
 
When asked about access to the nearest health facility from the respondent’s place of 
residence, the majority 97.8% (n=134) admitted they access the health facility on foot. 
Out of these, 32.8% (n=43) reported that it took them less than 15 minutes to arrive at 
the health facility on foot, 59.8% (n=77) arrived between 15 to 30 minutes on foot, and 
only 8.4% (n=11) took more than 30 minutes on foot to arrive at the nearest health 
facility. 
4.3.9 Living in Makana municipality during both onset of symptom and 
diagnosis 
 
Almost all (90.3%, n=121) of the patients interviewed were resident in Makana 
municipality as at the time of development of PTB symptoms and diagnosis. 
 
4.4 DELAY IN TB CASE FINDING 
 
Table 4.10 depicts the duration of the different types of delays in TB case finding. The 
mean patient delay from onset of symptom to first health care visit was 45 (±29.6) 
days. A majority (83.6%, n=112) of the respondents delayed for one month and above 
before seeking care. The mean health system delay from the time patient first visited 
a health care facility to the time of TB diagnosis was 16 (±13.1) days. Health system 
delay of 2 weeks and above was found among 62% (n=89) of the respondents while 
the mean total delay from the onset of symptoms to TB diagnosis was 60 (± 34) days. 
Therefore, in this study, patient delay contributed more than health system delay to 
the total delay in TB case finding. 
Table 4.10: Patient, health system and total delay in TB case finding in Makana 
Municipality 
Duration of delay in TB 
case finding 
Mean(standard 
deviation) (days) 
Median 
(days) 
Range 
(days) 
Inter-
quartile 
range 
Patient delay 
Patient delay of 1 month 
and above  
45(29.6) 
112patients 
28 
 
6-113 28-56 
Health system delay 
Health System Delay of 
2 weeks and above 
16(13.1) 
89 patients 
14 
 
2-112 6-14 
Total delay 60(34.0) 56 12-168 34-70 
 
 4.5 DETERMINANTS ASSOCIATED WITH DELAYED TB CASE FINDING 
Table 4.11 below gives the summary of the characteristics/determinants that had 
statistically significant associations with patient and health system delay among the 
study respondents. For the characteristics contained in the questionnaire but not 
presented in the table, their associations were found not to be statistically significant. 
Table 4.11 Statistically significant characteristics associated with patient and health 
system delay 
Characteristics  0dds ratio 
(confidence 
interval) 
p-
value 
Patient delay 
Gender 
Passive smoking 
Admitted during diagnosis 
Symptoms 
Cough as first symptom experienced 
presented coughing up blood 
Health seeking behaviour 
Place of first visit 
Number of different types of care sought 
Visited traditional/spiritual healer 
Visited pharmacy shop 
Prior awareness of TB before onset of illness 
Knowledge 
Knowledge level 
Believe that TB is caused by evil spirit 
Perception that male should take 
responsibility of their illness 
Stigma 
There is stigma in visiting TB clinics 
TB affect work performance 
Stigma level 
  
N/A 
N/A 
N/A 
 
3.6 (1.52-8.55) 
0.36(0.136-
0.933) 
 
0.28(0.14-
0.59) 
N/A 
5.57(1.97-
10.60) 
2.41(1.2-4.86) 
N/A 
 
2.77(1.3-5.7) 
0.32 (0.14-
0.74) 
0.35(0.16-
0.74) 
 
0.012 
0.017 
0.038 
 
0.003 
0.032 
 
0.001 
0.0001
0.0001
0.015 
0.048 
 
0.005 
0.007 
0.007 
 
0.0001
0.029 
0.023 
 
Why did you not seek care early 
believe they will get better on their own 
No reason 
 
3.9(1.8-8.4) 
N/A 
0.41(0.19-
0.88) 
 
3.6 (1.52-8.55) 
0.36(0.136-
0.933) 
0.003 
0.032 
HEALTH SYSTEM DELAY 
Characteristics 
Crowding index 
Financial status 
Passive smoking 
Symptoms 
First symptom experienced 
having difficulty in breathing as symptom 
presenting difficulty in breathing as a 
symptom 
presenting febrile illness as symptom 
health seeking behaviour 
No of types of care sought 
Pattern of consultation 
 
Stigma 
There is stigma with visiting TB clinic 
Level of stigma 
TB affect my relationship with people 
Feel ashamed I have TB/will not want people 
to know I had TB 
 
 
 
 
 
 
N/A 
0.32 (0.13-
0.77) 
3.1(1.17-8.23) 
 
N/A 
4.5 (1.6-12.6) 
2.48(1.06-
5.84) 
0.37(0.13-
1.00) 
 
N/A 
N/A 
 
N/A 
N/A 
N/A 
4.07 (1.60-
10.33) 
 
 
0.027 
0.007 
0.020 
 
0.027 
0.005 
0.040 
0.045 
 
0.011 
0.006 
 
0.0001
0.0001
0.001 
0.003 
 
  
Interestingly, the study found that having better knowledge about TB (symptoms, 
causation and prognosis) was associated with longer patient delay while it was not 
significantly associated with health system delay. The belief that HIV was caused by 
evil spirit was found to be associated with shorter patient delay. 
 
4.6 CONCLUSION 
 
This study has presented the research results as well as how the data was analysed. 
Estimates of the time delay in TB case finding related to the patient and the health 
system have been presented. In addition, a summary of the statistically significant 
determinants associated with patient and health system delay in TB case finding has 
been presented.  
Chapter 5 will discuss the main findings and will also highlight the limitations of the 
study and proffer some recommendations based on the research findings.  
 
 
 
 
 
 
 
 
 
  
 
 
CHAPTER 5 
               DISCUSSION, RECOMMENDATION AND CONCLUSION 
 
5.1 INTRODUCTION 
The previous chapter focussed on data analysis and presentation of main findings. 
This chapter discusses the results, offers some recommendations based on the study 
results and gives a conclusion of the study 
5.2 THE PURPOSE OF THE STUDY 
The purpose of the study was to determine the determinants that may be contributing 
to the delay in TB case finding among patients in Makana municipality. The specific 
objectives of the study include 
- To assess the duration of delay in TB case finding among PTB patients in 
Makana Municipality 
- To determine patient-related determinants contributing to delays in TB case 
finding among PTB patients registered for treatment in Makana Municipality. 
- To determine the health system-related determinants contributing to delays in 
TB case finding among PTB patients registered for treatment in Makana local 
Municipality. 
5.3 DISCUSSION OF RESULTS 
 
 The highlights of the study results will be discussed in comparison with existing 
academic literature on TB case finding.   
5.3.1 Demographic profile of TB patient in the Municipality 
 
This study found that among the study participant, slightly more males (55.2%) had 
PTB compared to females (44.8%). Other studies among PTB patients have found 
different gender distributions. While some studies (Wondimu et al.., 2007: 150; Van 
Wyk, Enarson, Beyers, Lombard & Hesseling 2011: 1071) found that more females 
had PTB, other similar studies also conducted in Sub-Saharan Africa (Lienhardt et al., 
2001: 234; Sendagire et al.., 2010: 4) found that more males were affected. This study 
also found that PTB is a disease that affects people during their youthful years since 
the majority (71%) of the patients in the study were between the ages of 25 – 45 years 
while the mean age of the patients was 38 (±10.4) years. This concurs with the finding 
of other similar studies in South Africa (Van Wyk et al.., 2011: 1071; Meintjes, et.al., 
2008: 75)  and Gambia (Lienhardt et al., 2001: 235) that found median ages of 30-36 
years. The implication of this is that PTB is a disease which, similar to HIV/AIDS, may 
potentially have a significant impact on the economy of South Africa as it affects the 
most productive members of the workforce. Furthermore, as shown in the result 
section above, TB tends to afflict the poor and unemployed who tend to have only 
limited education. This concurs with the reports in many scholarly articles that TB is a 
“disease of poverty” with the sufferers having illiteracy, poverty and unemployment 
rates higher than those of the general population (WORLD HEALTH ORGANIZATION, 
2006: 33). 
5.3.2 Patients characteristics 
 
 Distance to health facility: This study found that more than 91% of the patients 
arrived at their nearest health facility on foot within 30 minutes of walking. This 
suggests that accessibility to a health facility was not a problem for the patients in 
this Municipality. This is a testament of the government’s commitment to making 
healthcare accessible to the generality of the populace. Interestingly, 29% of the 
respondents still responded that “lack of money” contributed to their delay in visiting 
a health care facility after they had developed TB related symptom. It is reasonable 
to assume that this lack of money did not refer to the unavailability of transport fare 
to the clinic but rather to lack of money to buy groceries/food to eat. The lack of 
money (and their efforts to get some money) may have seized the respondents’ 
attention to the point that they neglected their health needs. 
5.3.3 Symptoms experienced 
 
 The majority of the symptoms reported in table 4.3 above are related to cough and 
other symptoms associated with chest infections. As only pulmonary TB patients were 
included in the study, it is not surprising that cough and lung infection-related 
symptoms predominate among the reported first symptom experienced and other 
symptoms experienced / reported to the health care provider. Table 4.3 also shows 
that the commonest symptoms reported during the course of the illness were 
constitutional illness (88.1%), febrile illness (84.3%) and cough (75.4%). This closely 
resembles the results of a similar study (Meintjes, et.al., 2008: 75) among PTB patients 
in a Cape Town hospital that found that constitutional illness was reported most (91%) 
by the patients followed by cough (78%) and febrile illness (53%). 
 
5.3.4 Knowledge, attitude and perception about TB 
 
Table 4.4 shows a paradox of some sorts. While majority of the patients were aware 
of TB as a disease prior to the onset of symptoms and also had fairly good knowledge 
about the causation and prognosis of the disease, only half of them could relate the 
symptoms to TB when they contracted the disease. This high awareness of TB among 
TB patients has been reported in Tanzania (Ngadaya, 2009: 199) and South Africa 
(Meintjes, et.al., 2008: 77). The inability of the patients to attribute the symptoms to 
TB despite their good knowledge may seem to validate the suggestion by Meintjes, 
et.al. (2008: 78) that knowledge of TB was not being “personalised”. However, there 
are still countries like Pakistan where knowledge about TB was reportedly generally 
poor. For example, less than 40% of the TB patients that participated in a study in that 
country knew that TB was infectious (WORLD HEALTH ORGANIZATION, 2006: 34). 
This poor knowledge was attributed to inadequate and ineffective health education.  
Furthermore, the assumption by more than a third of the patients that their symptoms 
were those of HIV may be fuelling the stigma associated with TB.  
Regarding the source of health information, more (71%) of the patients relied on the 
media for their health education compared to the 38% that heard from the health care 
worker. The danger is that the message disseminated by the media, being 
uncensored, may contain inaccurate information. It is therefore critical that the health 
system take steps to establish itself as the main provider of health education to the 
population of Makana Municipality. 
   
5.3.5 TB and stigma 
 
Stigma is one factor that has consistently been reported in the literature as a factor 
associated with TB case finding delay (WORLD HEALTH ORGANIZATION, 2006: 34; 
Moller and Erstad, 2007: 113). The study found that only a negligible proportion (1.5%) 
of the respondents denied experiencing and feeling any form of stigma as a result of 
TB infection.  
The stigma associated with TB may be linked to its close association with HIV (an 
even more stigmatised disease) as well as the notion, according to Crowford in Moller 
and Erstad (2007: 116), that ill-health is symptomatic of moral indiscipline. 
 
5.3.6 Delay in TB case finding 
 
This study found that patient delay contributed more to total delay than health system 
delay. There has been no consistent pattern, in academic literature, in the relative 
contribution of patient and health system determinants to total delay in TB case finding 
(Storla et al.., 2008: 3).  Some studies have found patient determinants to contribute 
more to total delay (Tegegn & Yazachew, 2009: 32; WORLD HEALTH 
ORGANIZATION, 2006a: 24; Ngadaya et al., 2009:4; Storal et al., 2008:3-4 ), others 
found that health system determinants contributed more to delay (Van Wyk, et al., 
2011: 1073; Wondimu et al., 2007: 148; Lonnrot, Aung, Maung, Kluge & Uplekar, 
2007:160; Mpungu, Karamagi, & Mayanja, 2005:5; STOP TB Partners 2008:11) while 
yet others found that patient and health system delay were comparable 
(Sreeramareddy et al., 2009: 4; Sendagire et al., 2010: 4) 
The finding of this study was different from two South African studies conducted in the 
Western Cape Province (Van Wyk et al., 2011:1073; Meintjes et al., 2008:76) that 
found that health system delay had greater contribution to total delay than patient 
delay. A number of reasons may justify that. One of the studies (Meintjes et al., 
2008:76) was conducted among admitted patients in a secondary level hospital. As 
such, they may have experienced a longer health system delay as a result of the time 
elapsed during referral from primary health facilities. The 2nd South African study which 
was also a clinic based study (Van Wyk et al., 2011:1073) interestingly, found a 
median health system delay of 17 days which is comparable to that found in this study 
(14 days). The much shorter patient delay recorded in the Cape Town clinic study may 
be as a result of increased TB knowledge, lesser stigma or a more effective health 
education system in the Cape Town area compared to the predominantly rural setting 
of this study. This study, thus, supports the assertion that determinants affecting TB 
case finding may differ within countries (Van Wyk et al., 2011:1073). Two Ethiopian 
studies have shown this ‘within-country’ difference in the contribution to total delay 
between patient and health system. While one reported greater contribution by patient 
delay in one setting (Ayalew & Maseret, 2009; 32) another study (Wondimu et al.., 
2007: 150) conducted in another region of Ethiopia reported health system delay that 
is much longer than patient delay. 
The implication of the longer patient delay found in this study is that the patients remain 
infectious in the community for a longer period and spread the infection before they 
come in contact with the health system (Golub et al.,2006:24, CDC, 2005:32; WORLD 
HEALTH ORGANIZATION, 2006:10). This may be part of the ill-understood reasons 
why the study setting was the district with the second highest TB incidence rate in 
South Africa in 2010 and also why Cacadu District continues to have very high 
numbers of new smear positive cases despite having a significant improvement in the 
TB cure rate (Massyn et al.., 2013: 194-198).     
5.3.7 Determinants contributing to delays in TB case finding 
 
Some delay determinants are attributable to the patients’ not seeking medical attention 
timeously from health care facilities/providers while others relate more to the health 
care system’s delay in suspecting, investigating and diagnosing TB (Sreeramareddy 
et al., 2009: 2). What constitutes a risk factor for delay in TB case detection in one 
setting may well be an enabling factor for early detection in another setting (Storal, et 
al., 2008:3). Additionally, determinants have also been demonstrated to have some 
interrelationship and may differ between and within settings (Storla, et al., 2008; 3; 
Finnie et al., 2011:397-406). 
   
5.3.7.1 Demographic determinants 
 
This study found that males were more likely to have more patient delay in TB case 
finding that females. This may be because females tend to visit the hospital more 
frequently than males for other reasons such as ante-natal visits (many of the study 
respondents are of child-bearing age) and may, thus, have more health knowledge 
than their male counterparts. This finding was similar to the finding in the Amazon 
region which found the male gender to be associated with more patient delay (Ford et 
al., 2009:1100). On the contrary, other studies have found the female gender to be 
associated with more patient delay (Fatiregun & Ejeckam, 2010:5; Wondimu  et al., 
2007: 151; WORLD HEALTH ORGANIZATION, 2006a:24, Sendagire et al.., 2010; 4). 
This was thought to be due to the fact that females have limited decision making 
powers, are pre-occupied with domestic duties, may be unemployed and may have 
constrains in resolving their health needs (Fatiregun & Ejeckam, 2010: 7; Wondimu et 
al., 2007: 155). Perhaps this may not have been the case in this study setting. 
This study also found that the more affluent respondents had less health system delay 
than their poorer counterparts. However, educational level, employment status and 
marital status were not associated with any type (patient or health system) of delay in 
TB case finding. The socioeconomic status of the patient has been implicated both as 
an enabler as well as a barrier to early TB case detection in different researches. The 
finding of this study was similar to those of studies in Ethiopia (Wondimu, et al., 
2007:151) and Kampala Uganda (Mpungu, Karamagi, & Mayanja, 2005:5) which 
reported that educational status and monthly income were not associated with patient 
delay. On the other hand, other studies found that prior formal education was 
associated with less delay (Ayalew & Maseret, 2009: 32; WORLD HEALTH 
ORGANIZATION, 2006a: 28; Ford et al., 2009:1100). Similarly, while being a 
housewife or a married woman were both reported to be associated with patient delay 
in Malawi and India respectively (Gosoniu, Ganapathy , Kemp, Auer, Somma,  Karim,& 
Weiss,  2008 : 848), in Ethiopia, being  divorced, was instead found to be a risk factor 
for patient delay (Ayalew & Maseret, 2009: 32). 
   
5.3.7.2 Presenting symptoms 
 
This study found that cough, as an initial symptom, was associated with more patient 
delay. This may be because cough with sputum is a symptom that is wide spread in 
many societies (Storla et al., 2008: 2). Hence the delay may be due to TB patients 
initially attributing their symptoms to other illnesses and not seeking formal medical 
assistance. Likewise, breathing with difficulty may be attributed to other diseases like 
asthma. However, some symptoms like coughing up blood, unexplained weight loss, 
fever and general body aches have been associated with seeking medical diagnosis 
and help earlier (Gosoniu et al., 2008: 848, Ford et al., 2009:1099).  Indeed, this is in 
line with the finding of this study which recorded shorter delay with coughing up blood 
and febrile illness. Passive smoking was found to be associated with longer patient 
and health system delay.  This may be because passive smokers may be used to 
chronic cough and may thus mistake their cough to be due to the smoke they had 
inhaled (Mpungu, Karamagi, & Mayanja, 2005: 5). Interestingly, however, Wondimu et 
al. (2007: 150) found no statistically significant difference in patient or health system 
delay for the different TB symptoms, either individually or in group. 
5.3.7.3 TB stigma 
 
This study found that stigma was associated with both patient and health system 
delay. The stigma of being seen at the TB clinic was associated with longer patient 
and health system delay. In the context of this study, while there is no designated ‘TB 
clinic’, the practice throughout all the primary health clinics in the Municipality, of 
attending to TB patients at a designated time (very early in the morning) and room was 
viewed by the patients as attending a “TB clinic”. Table 5.0 shows other aspects of the 
TB stigma associated with both patient and health system delay. 
TB has been stigmatized over the years, partly due to its symptoms. Stigma has been 
described as an ideology that identifies and links the presence of biological disease 
causing agents in the body or signs of the disease to negatively defined behaviours or 
groups in the society (Moller & Erstad, 2007: 107). The close association of TB with 
HIV in recent years has made TB stigma to become even stronger (Moller & Erstad, 
2007: 114). Many studies have linked stigma with delay in TB case finding. The fear 
of being diagnosed with TB and subsequent isolation were significantly associated 
with delay in the Eastern Meditarranean region (WORLD HEALTH ORGANIZATION, 
2006a: 34) and Nigeria (Fatiregun & Ejeckam, 2010: 7). Also a study among Cape 
Town TB patients found that there was delay, especially among the Xhosa patients, in 
seeking help at the local clinics for fear of being respondentsed to an HIV test or being  
labelled as HIV positive if community members saw them walking to the clinic regularly 
(Skordis-Worrall, Hanson & Mills 2010: 176). Ironically, no association was found 
between stigma and delayed TB case finding in the Amazon (Ford et al., 2009: 1100) 
and Kampala, Uganda (Mpungu, Karamagi, & Mayanja, 2005:1) and the WORLD 
HEALTH ORGANIZATION (2006:24) even reported  that in Somalia,  stigma 
associated with the development of full blown TB may have motivated TB sufferers to 
seek help early 
 
5.3.7.4 Knowledge about TB 
 
This study found that more knowledge about TB was associated with longer patient 
delay but was not associated with health system delay. This may be due to the greater 
likelihood of the patient equally having knowledge of other diseases that have 
symptoms similar to those of TB and thus failed to personalise his/her symptoms 
(Meintjes, et al., 2008: 78). However this was contrary to other studies in Ethiopia 
(Ayalew & Maseret, 2009: 32) and Syria (WORLD HEALTH ORGANIZATION, 2006a: 
24) that found that prior knowledge about TB was associated with less delay. Another 
study (Fatiregun & Ejeckam, 2010: 5) found though, that good knowledge about TB 
was not associated with time duration of TB case finding.   
5.3.7.5 Health seeking behaviour 
 
This study found that visiting a government health facility (state-owned clinic or 
hospital) first was associated with less patient delay while visiting traditional /spiritual 
healers and pharmacy shops was associated with longer patient delay. This may be 
due to the fact that traditional/spiritual healers, pharmacy shops in South Africa are 
outside the National TB Control Programme (NTCP) (Van Wyk, et al., 2011: 1069; 
Ndjeka et al., 2008:48). And there is minimal TB surveillance in this sector of the health 
system and little engagement with the NTCP (Van Wyk, et al., 2011: 1069). Only 
government health facilities are within the NTCP in South Africa. Other studies have 
similarly reported that seeking help from non-specialized individuals like traditional 
healers  is associated with longer delays in TB case finding (WORLD HEALTH 
ORGANIZATION, 2006a: 24; Storal et al., 2008: 6; Finnie et al., 2011: 397, 407; 
Wondimu et al., 2007:154) 
In this study, private practitioners were consulted by a very insignificant proportion of 
the patients (2.2%) so the report by other studies (Ayalew & Maseret, 2009: 32; Van 
Wyk, et al., 2011: 1073; WORLD HEALTH ORGANIZATION, 2006a: 28) that 
consulting them was associated with longer delay in TB case finding could not be 
investigated in this study. 
This study also found that visiting multiple care providers was associated with longer 
patients and health system delays. This is similar to the reports in literature (Skordis-
Worrall et al., 2010: 177; Mpungu, Karamagi, & Mayanja, 2005: 5; Van Wyk, et al., 
2011: 1075) that visiting multiple care providers at the onset of symptoms is associated 
with delay 
5.3.7.6 Distance to health facility 
 
This study found that there was no statistically significant association between 
distance from health facility and delay in TB case finding. This may be due to the fact 
that a majority (92.6%) of the TB patients access the nearest health facility on foot 
within 30 minutes. This is also similar to the situation reported in Kampala, Uganda 
(Sendagire et al., 2010: 4) where there was no significant association between a TB 
patient’s area of residence (distance to nearest health facility) and delay in TB case 
finding. However, studies where there was wide variations in the distances of TB 
patients’ residences to nearest facility, have reported an association between  those 
living further away from the health facilities with longer delays in TB case finding 
(Finnie et al., 2011: 397; Fatiregun & Ejeckam, 2010:6). 
5.4 LIMITATIONS OF THE STUDY 
 
A limitation of this study was the reliance on accurate recollections of past events by 
the patients rather than on documented records. Hence, there is a risk of recall bias. 
However this was mitigated in the study by using time ranges for time related questions 
and the use of multiple questions to explore a single theme. Also, such issues such 
as visit to a traditional healer may have been under-reported by the patients for fear 
of criticism. Additionally, sampling a much larger sample size may have yielded results 
that would have been more representative of the situation in Makana Municipality but 
that was logistically impossible as there were financial and time constraints.  Since the 
study was conducted only at clinics in Makana Municipality, these findings can neither 
be generalizable to in-hospital TB patients in Makana Municipality nor to PTB patients 
at clinics in other municipalities. 
5.5 RECOMMENDATIONS 
 
Based on the results of the study, the following recommendations are being made: 
5.5.1 Health education 
 
 TB educational campaigns should be intensified in the Municipality. As the media was 
found to be commonest source of health information for the patients, all efforts should 
be made to ensure that only accurate (and not just sensational ‘news worthy’) TB 
health information is passed on to the populace using by the media.  The Municipal 
TB programme should also revive and/or intensify the health facility based health 
education programme as health care workers were found to be less frequently cited 
sources of health information even though they have the best chance of 
communicating the most accurate TB health information to the patients. 
Whatever channel of communication is used, the health education message should 
dispel the myths surrounding TB and particularly address the issue of stigma 
associated with TB as this has been found to contribute to delay in both patient and 
health system delays. This is also in line with the recommendation of the WORLD 
HEALTH ORGANIZATION (2006: 34) that the issue of TB stigma should be tackled 
head on by any TB health education programme. Additionally, the health education 
campaigns should be specifically taken to schools as the typical profile of a TB patient 
in the municipality (as found by the study) is a young, single, unemployed youth/adult 
with secondary or high school level education.  
 5.5.2 Health promotion 
 
 Health education should encourage the populace to seek medical attention only at 
government facilities when they develop TB related symptoms as these are the only 
health facilities currently operating within the National TB Control Programme (NTCP). 
However, this study would seem to support a collaboration with/training of non-NTCP 
providers (like traditional/spiritual healers, private practitioners, pharmacy shops, etc) 
to encourage them to urgently refer all TB suspects, who consult them, to government 
health facilities for prompt diagnosis.  
5.5.3 Integration of the TB clinic within the mainstream outpatient clinic 
    
 This study found that the current practice of attending to TB patients at one corner of 
the clinic at specific times (usually very early in the morning) or in a designated room 
in the clinic was viewed as stigmatizing by the patients and contributed to both patient 
and health system delays. It is therefore recommended that TB patients should not be 
easily identifiable or isolated at the clinic in any manner. If the waiting areas of the 
clinics are well ventilated and waiting times are short, the risk of infection of other 
patients will be low. Information gathered showed that ARV clinics in the municipality 
were recently integrated into the mainstream out-patient departments successfully. 
The TB clinics should also be similarly integrated. 
5.5.4 Training of clinic nurses on the clinical features and management of TB 
 
The study found that some TB symptoms were associated with longer and shorter 
health system delays. It is therefore important that all clinic nurses who manage TB 
patients are sent on TB workshops and trainings at regular intervals to re-freshen their 
knowledge on the wide range of TB symptoms. Pamphlets should be distributed at 
health facilities reminding visitors to the clinic that cough is a common symptom of TB. 
Additionally, patients to the health facilities should be actively triaged and asked if they 
have cough and be screened for TB if the answer is in the affirmative.  
   
5.5.5. Improvement of sputum turn-around time 
 
There is need to strengthen the entire chain of sputum collection, sputum testing at 
National Health Laboratory Service (NHLS), reception of sputum results at the clinics 
and giving of results to the patients. All issues negatively affecting sputum turn-around 
time along this chain should be investigated and resolved timeously. 
 
5.5.6 Recommendation for future research 
 
The following should be considered as possible topics for future research: 
 A qualitative study to explore, in depth, the myths and stigma associated with 
TB as a disease. 
 A study to investigate the determinants affecting sputum results turnaround 
time in the municipality. A mixed method would be best; an initial quantitative 
study determining the existence or otherwise of an unacceptably long sputum 
test result turnaround time, followed by a qualitative study that will explore the 
determinants identified in the quantitative study. 
 A qualitative study to further explore, in depth, the specific role of traditional 
healers and culture in the TB case detection delays.  
5.6 CONCLUSION 
 
This study investigated the time delay of TB case finding among TB patients receiving 
treatment at the clinics in Makana Municipality as at the time of data collection of this 
study. It also identified determinants, unique to Makana Municipality, that affect TB 
case finding. The results of this study informed a number of practical and 
implementable recommendations that were suggested. It is the hope that this original 
research work, which is to be shared with the Municipal and Provincial TB 
Directorates, will serve as a piece of scientific evidence that will inform modifications 
or improvements in the current TB control programme in the Makana Municipality. The 
suggested further research will also explore, in greater depth, some of the issues that 
this study have raised which, if still poorly comprehended, will continue to hamper 
efforts to eliminate delay in TB case finding in the Municipality. 
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 Annexure D: Informed consent form (English version) 
CONSENT: RQUEST TO THE STUDY RESPONDENTS REQUESTING TO 
PARTICIPATE IN MY STUDY  
University of South Africa (UNISA), 
Department of Health Studies, 
Researcher: Ms. Okolo Juliet. O, 
Supervisor: Mrs Makua M.R. 
Dear Sir/Madam/Miss. 
A letter requesting for your consent to participate in my study 
My name is Ms Okolo Juliet O, a postgraduate student of Masters of Public Health, 
University of South Africa (UNISA).  To complete my degree I am conducting a study 
in collaboration with the University of South Africa. The title of the study is 
“Determinants of delayed TB case-finding among pulmonary TB patients at the 
primary health care clinics in Makana Local Municipality, Eastern Cape” I would 
like you to participate in the study. 
Your participation will enable us to understand the determinants contributing to 
delays in the detection of TB cases and also to estimate the time duration of this 
delay. The information you provided will be published and is hoped to enable health 
authorities in Makana Municipality to plan adequately on strategies for optimising 
early detection of TB cases which will ultimately benefit the TB patients. The study 
will cause no harm to you but if the interview is causing any psychological 
uneasiness, I have the service of a counsellor available to you free of charge. The 
study procedure, including responding to a questionnaire will take about 20minutes 
of your time. 
Your participation is totally voluntary and you have the right to withdraw from the 
interview at any time. You are not required to indicate your name or any form of 
identification on the questionnaire. The information you will give us will be kept 
confidential. The interview will be collected in a private area/room in the study 
setting, and the information will not be shared with any person known to you and will 
not be reported in a manner that will identify you.  
If you sign this consent form, it means that 
 You understand the reason for the research 
 You understand the topic of the research 
 You understand the process of the research 
 You voluntarily decided to participate in the study and you experienced no 
pressure from anybody to participate. 
 You understand that you have the right to withdraw at any stage without 
giving any reason and this will not negatively affect you in any way  
 You understand that the information you supplied will remain confidential and 
no information will be linked to your name 
Thanks for your anticipated co operation. 
 
Signature of participant ……..…………  
Date……………………………………… 
You are free to ask any question about the study or about being a participant and 
you may call Ms Okolo at XXXXXXXXX if you have further questions. Should you 
have any questions regarding this study or wish to report any problems you have 
experienced relating to the study, please contact the study coordinator: 
Study Coordinator’s Name: Mrs Makua, M.R 
University of the South Africa 
Telephone: 0124296754 
Email: makuamr@unisa.ac.za 
 
 
 
 
Annexure E: Informed consent form (Xhosa version) 
IFOMU YESIVUMELWANO KUBANTU ABAZAKUTHATHA INXAXHEBA 
MALUNGA NOPHANDO-NZULU 
University of South Africa (UNISA), 
Department of Health Studies, 
Umphandi: Ms. Okolo Juliet. O, 
Umanejala: Mrs Makua M.R. 
Ndiyabulisa Manene nani Manenekazi 
Esi sisicelo mvume sokuba uthathe inxaxheba koluphando-nzulu 
Igama lam ndingu Ms Okolo Juliet, ndingumfundi onesidanga owenza imfundo 
enomsila malunga nesebe lezempilo, kwi Univesiti I UNISA. Ukuze ndikwazi 
ukufumana isidanga sam, kufuneka ndenze uphando-nzulu ndikunye ne univesiti 
(UNISA), oluphando lubizwa ngokuba “Uphando nzulu ngezizathu  ezenza 
kuthathe ixesha ukufumaniseka kwesifo sephepha (TB) kwizigulana kwiklinki 
eziku Masipala waseMakana , kwiphondo lase Mpuma-Koloni.” 
Ukuthatha kwakho inxaxheba kuyakwenza ukuba sikwazi ukufumana izizathu 
ezibangela oku, sikwazi nokuqikelela ixesha elithathwayo phambi kokuba umntu 
afunyansiwe enesifo sephepha.  Izimvo zakho zizakubhalwa phantsi kwiphepha 
elakuthi lipapashwe, ngethemba lokuba ziyakuthi zincedisane namagosa ezempilo 
ase Makana ukuhlangabezana  nezidingo zezigulana zesifo sephepha. Akukho 
bungozi buza noluphando, kodwa ukuba ufumanisa ukuba awuphathekanga kakuhle 
ngokwasemphefumlweni emva kwale mibuzo, ukhona umntu onokuthetha naye 
endingakudibansia naye, mahala, akukho mali ozakuyihlawula. 
Imibuzo le endizakuyibuza yona ayizukudlula kwimizuzu eyi 20. Akunyanzelekanga 
ukuba uxele igama lakho, kwaye kuzakugcinwa kuyimfihlo okuthethileyo, Imibizo le 
izakwenziwa bucala, kwaye okuthethileyo kuzakugcinwa kuyimfihlo ebantwini 
obaziyo, Kwaye siyaqinisekisa ukuba kuzakubhalwa ngendlela ezakwenza ukuba 
kungabikho kukrokreleka  ukuba intetho le ivela kuwe. 
Xa usayina apha eli phepha, uvuma oku  kulandelayo: 
 Uyavuma ukuba uyayazi injongo yoluphando 
 Uyavuma ukuba uyasazi isihloko soluphando 
 Uyavuma ukuba uyayazi indlela ekuzakwenziwa ngalo luphando 
 Uyavuma ukuba awunyanzeliswanga ukuba uthathe inxaxheba 
 Uyavuma ukuba uyayazi ukuba unelungelo lokuba ungalimisa uphando olu, 
ungaqhubekeki, kwaye lonto ayizukwenza ukuba ungaphatheki kakuhle 
 Uyavuma ukuba uyayazi ukuba okuthethileo kuzakugcinwa kuyimfihlo, kwaye 
akuyi kwayanyaniswa nawe 
Enkosi ngentsebenzisiswano yakho. 
 
Sayina apha……..……………….  
Umhla……………………………………… 
 
Wamkelekile ukuba ungabuza imibuzo nenkcazelo’banzi malunga noluphando, 
okanye xa uthe wanesikhalazo, ungaqhakamishelana no Ms Okolo kule nombolo 
XXXXXXXX 
 
Umphathi wophando: Mrs Makua, M.R 
University of the South Africa 
Telephone: 0124296754 
Email: makuamr@unisa.ac.za 
 
 
 
 
 
 
Annexure F: Informed consent form (Xhosa version) 
Please answer the question as honestly. You are not required to indicate your name 
and the information you provide will be kept confidential. Your participation is 
voluntary and you can terminate the session without any penalty.  
Individual’s Questionnaire Number:  
 
Date: ------------------------------------- 
 
SECTION A: Demographic information 
No Question Please give your response here (Tick 
appropriate answer) 
1 Gender Male          (         ) 
Female       (         ) 
2 Age (in years as at your last 
birthday) 
………… ………….. 
3 Number of people living in the 
same house 
 
................................... 
4 Marital status Married                        (         ) 
Single                          (         ) 
living together             (         ) 
Divorced/Separated     (         ) 
Widowed                      (         ) 
5 Highest educational level 
completed 
No formal education                        (         ) 
Grade 1-6                                        (         ) 
Grade 7-9                                        (         ) 
 Grade 10-12                                    (         ) 
Any university or higher education (         ) if 
yes please 
specify(……………………………………..) 
6 Employment status Unemployed            (         ) 
 Employed               (         ) 
Casual work            (         ) 
Grant/pensioned      (         ) 
Student                    (         ) 
Others (Please 
specify)……………………………………… 
7 Please indicate what best 
describes your financial 
status? 
You have savings (            ) 
Your income just covers your 
expenses 
 
(            ) 
 
You are in debt (            ) 
SECTION B: PERSONAL  HABITS 
8 Do you smoke cigarettes? Never                             (            ) 
Currently  smoking       (            ) 
Quitted smoking           (            ) 
9 Do you or did you ever live 
with somebody World health 
Organization smokes in the 
house 
Yes       (            ) 
No        (            ) 
10 If currently smoking, for 
how long have you been 
smoking? 
Years……..; Months…………….. 
 
SECTION C:  Patient’s characteristics: 
No Question Indicate your response 
here 
11 Before you were diagnosed with TB did you have 
any other lung disease? 
Yes   (         ) 
No   (         ) 
12 Have you had TB before?      Yes   (        )  
No   (         ) 
13 If yes, how many times before this current TB? Please specify 
………………… 
14 Are you currently on treatment for Drug-resistant 
TB 
Yes   (            ) 
No    (            ) 
15 Were you   admitted in a hospital at the time you 
were diagnosed of TB? 
Yes   (        )  
No   (         ) 
 
SECTION D: Symptoms experienced 
N
o 
Questions Response  
16 Please indicate the “first” symptom you experienced before you were 
diagnosed of TB (tick as appropriate) 
Cough less than 2weeks (         ) 
Cough more than 2weeks (         ) 
Coughing up blood (         ) 
Chest pain (         ) 
 Difficulty in breathing (         ) 
Increased sweating at night, even during cold 
days 
(         ) 
Fever (         ) 
Fatigue (         ) 
Unintentional weight loss (         ) 
Loss of appetite (         ) 
Others (specify)………………………………….  
……………………………………… 
17 Please list all the other symptoms you had before you were diagnosed of 
TB…………………………. 
……………………………………………………………………………………………
……………………………………………………………………………………………
…………………………….. 
 
SECTION E: Types of care sought, reason for choice of first consultation, and 
care received 
N
o 
Question Indicate your response here 
1
8 
What did you think was wrong with you when you had TB related 
symptoms? 
I thought it was HIV                                    (               ) 
I thought I had cold or flu                            (               ) 
I thought it was TB                                      (               ) 
I thought it was another medical condition (               ) 
I thought I was bewitched                            (               ) 
I thought I had psychological distress          (               ) 
I did not know what was wrong with me      (               ) 
Others 
(specify)………………………………………….…………………………………………
………. 
1
9 
Did  you seek medical care immediately you had 
your first TB related symptoms 
Yes  (         ) 
No   (         ) 
2
0 
If  “No” what made you to wait before seeking medical attention? (you can 
tick more than one if applicable) 
Thought I will get better without treatment                (         ) 
Fear of being diagnosed with TB                                 (         ) 
Fear of social isolation(stigma) if diagnosed with TB (         ) 
Lack of money                                                               (         ) 
Fear of a compulsory HIV test                                      (         ) 
No specific reason                                                         (         ) 
I was busy                                                                     (         ) 
Others 
(Specify)……………………………………………………………………………………
….  
2
1 
Which one of these health facilities did you visit 
FIRST when you had TB related symptoms? 
 Clinic                                       
(       ) 
Government  hospital               
(       ) 
Private health facility                
(       ) 
2
2 
Please indicate ALL the reasons for visiting this health facility you ticked 
above first? ( you may tick more than one) 
The health facility was located close to my residence  (           ) 
I was confident of getting cured there                           (           ) 
Was advised by friends and relatives                            (           ) 
I was referred by other health services                         (           ) 
The services were free                                                (           ) 
I had no reason                                                      (           ) 
Others 
(specify)……………………………………………………………………………………
……….. 
2
3 
Please indicate ALL the reasons for NOT visiting the other health facilities 
first? ( you may tick more than one if applicable) 
I did not think I would get any help there (            ) 
It was far from my place of residence        (          ) 
There is always a long queue there             (         ) 
I had a previous bad experience there         (         ) 
I do not like the staff attitude  there             (        ) 
I had no reason                                             (        ) 
Others 
(Specify……………………………………………………………………………………
……… 
2
4 
How long after you had FIRST TB related 
symptom did you make this first visit to this 
health facility you chose in question 21? 
I-6 days               (         ) 
1- 2weeks            (         ) 
2-4 weeks            (        ) 
1 -2 months         (         ) 
2-4months           (         ) 
>4months             (         ) 
 
If >4months  specify 
…………………. 
25 
Please Tick all the symptoms that you told the health care provider during this 
your first visit 
Cough less than 2weeks (         ) 
Cough more than 2weeks (         ) 
Coughing up blood (         ) 
Chest pain (         ) 
 Difficulty in breathing (         ) 
Increased sweating at night, even 
during cold days 
(         ) 
Fever (         ) 
Fatigue (         ) 
Unintentional weight loss (         ) 
Loss of appetite (         ) 
Others (specify)………………………………….  ……………………………………… 
 
2
6 
What actions took place during your initial visits to the health facility you 
chose in question 22   (Tick where appropriate) (you may tick more than 
one) 
I did not tell the health worker all the 
symptoms I experienced 
(         ) 
I was initially given repeated courses of  
antibiotics 
(         ) 
I was asked to give a sputum specimen for TB 
test 
(         ) 
 I had   two Negative sputum smear results (         ) 
I was sent for chest X-ray (         ) 
I cannot remember (         ) 
Others(Specify……………………………………………………………………………
…………………. 
2
7 
How long after you submitted your sputum for test were you given your TB test 
results?  
Within 2 days              (           ) 
More than two days    (           ) 
28 
If your answer is “ more than two days”, please indicate the 
reason for your answer 
Ye
s 
No 
I did not go back to the clinic after the sputum was collected   
I did not go back to the clinic on time to fetch my result   
The date I was given to come and collect my result was more than 
two days 
  
Others( 
specify)………………………………………………………………………………… 
 
2
9 
At which of  these  three health facilities were you 
finally diagnosed of TB 
Clinic                                    
(       ) 
Government  hospital           
(       ) 
Private health facility           
(       ) 
3
0 
How long after your first visit to the health facility 
you chose in question 21 were you started on TB 
treatment  
Within 2 days (         ) 
3-6days          (         ) 
1-2weeks        (         ) 
2-4weeks        (         ) 
1-2months      (         ) 
2-4months      (         ) 
>4months       (         ) 
 
If >4months  specify 
…………… 
3
1 
How many times (in-total) did you visit health facilities for your TB 
symptoms before you were diagnosed of TB? ………………………. 
 
 
3
2 
When you had TB related symptoms, did you take any of the actions below 
before you visited a health facility? (please mark them in the order you took 
the actions (example 1st , 2nd, etc) 
Visited traditional healer                             (        ) 
Visited spiritual healer                                (        ) 
Used oral Herb                                            (        ) 
Used medication at pharmacy shops           (        ) 
I did not take any of the actions above        (        ) 
Others 
(Specify)………………………………………………………………………...................
................ 
 
SECTION F: Role of health system in raising community awareness about TB 
disease/ patient’s perception about TB   
N
o 
Questions Indicate your 
response here 
33 Did you know there is a disease called TB before you 
were diagnosed of TB? 
Yes    (       ) 
No     (       ) 
34 If YES, how did you get information about TB disease before you were 
diagnosed of TB? (Tick more than one if applicable) 
Friends/relatives                                            (         ) 
Media                                                             (         ) 
 Health care worker in the community          (         ) 
Health talks in the health care facility           (         ) 
Others (Specify)  
……………………………………………………………………………. 
35 Which of the following is true about TB? (Please 
tick Yes/No/Don’t know) 
Yes No Don’t 
know 
TB is caused by bacteria    
TB is caused by evil spirit    
TB is curable    
TB is infectious    
TB is hereditary    
Males are expected to take care of their own health 
(especially when symptoms are mild) 
   
 SECTION G: TB STIGMA (please tick either Yes, No, or I don’t know to these 
questions) 
No Question YES  NO I DON’T KNOW 
36 I feel ashamed of having TB    
I do not want other people to know that I have 
TB 
   
TB affects my relation with other people    
Tb affects my work performance    
Every person World health Organization has 
TB has HIV 
   
The chance of a girl getting married is limited 
if she had TB 
   
I will not want to be near someone who has 
TB 
   
There is stigma associated with visiting a TB 
clinic 
   
I would feel embarrassed if a family member 
has TB 
   
 
SECTION H: Access to health care 
No Question Indicate your response 
here 
37 What mode of transport do you usually use to 
go to the nearest health facility close to your 
place of residence? 
Walk                        (        ) 
Public transport       (        )      
Own transport          (        ) 
38 How long does it take you to get to this health 
facility using your usual mode of transport? 
<15minutes              (        ) 
15-30minutes           (        ) 
 30-60minutes          (        ) 
 > 60minutes            (        ) 
 
SECTION I: Exploration that findings above pertain to Makana Municipality 
health system 
39 Were you living within Makana Municipality when you first had TB symptoms?  
YES  (         )                                   NO (         ) 
40 Where you living within Makana Municipality when you were diagnosed of TB?   
YES   (       )                                  NO   (        ) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Annexure G: Questionnaire (Xhosa version) 
Sicela uphendule lemibuzo ilandelayo ngokunyanisekileyo. Akukho sinyanzeliso 
sokuba unikezele ngegama lakho, kwaye impendulo zakho zizakugcinwa ziyimfihlo. 
Akukho sinyanzeliso sokuba uthathe inxaxheba kule mibuzo, kwaye unelungelo 
lokungaqhubekeki  nemibuzo xa uziva ungakhululekanga.  
 
Inombolo yephepha:  
Umhla:: ------------------------------------- 
Background questions 
No Umbuzo Nceda unikezele impedulo zakho apha (bhala 
unxa) 
1 Isini/Ubuni Indoda            (         ) 
Umfazi           (         ) 
2 Mingaphi iminyaka yakho? 
(beka leminyaka 
sowuyigqibile) 
 
 
………… ………….. 
3 Bangaphi abantu ohlala 
nabo endlini ohlala kuyo 
 
………………………… 
4 Inkcukacha zomtshato Awutshatanga/awunamntu uncuma naye               
(         ) 
Utshatile                                                                  
(         ) 
Niyahlalisana                                                           
(         ) 
Wahlukene neqabane lakho lomtshato                   
(         ) 
Uswelekelwe liqabane lakho lomtshato                  
(         ) 
5 Amabanga emfundo Awuzange uye eskolweni                 (         ) 
Ibanga 1-6                                        (         ) 
Ibanga 7-9                                        (         ) 
Ibanga 10-12                                    (         ) 
Imfundo yaseUnivesiti                     (         )  
ukuba kunjalo yeyiphi imfundo enomsila 
onayo(……………………………………..) 
6 Inkcukacha 
ngomsebenzi/ingqesho 
Awuphangeli                                                        (  
) 
Uyaphangela                                                         
(         ) 
Uphangela isingxungxo                                        
(         ) 
Ufumana indodla okanye umhlala phantsi           (  
) 
umgumfundi                                                          
(         ) 
Enye indlela ophila ngayo engekho kwezi 
zingentla 
(cacisa)…………………………………………… 
 
7 Nceda cacisa uphila phantsi 
kwesiphi  isimo semali? 
Unayo imali 
oyigcinilelyo
(            )  
 
 Umvuzo 
wakho 
wanele 
ingxaki 
zakho, 
ingabikho 
imali 
eshiyekayo  
 
(            ) 
 
usematyale
ni 
(            ) 
8 Uyalitshaya icuba? Zange nditshaye                            (            ) 
Ndiyatshaya                                  (            ) 
Benditshaya, ngoku ndiyekile       (           ) 
 
9 Uhlala nomntu otshaya 
icuba ekhayeni lakho/ 
okanye wakhe wahlala 
nomntu otshaya icuba?   
 
…………………………………………. 
10 Lixesha elingakanani 
utshaya? 
 
Iminyaka…………………., 
iinyanga……………….. 
 
 Inkcukacha zesigulana: 
No Imibuzo Bhala impendulo zakho 
apha 
11 Phambi kokuba ufunyaniswe unesifo 
semiphunga (TB), wakhe wanaso isigulo 
esayanyaniswa nemiphunga 
Ewe   (         ) 
Hayi  (         ) 
12 Wakhe wanaso isifo semiphunga ngaphambili 
(TB)?      
Ewe   (        )  
Hayi   (         ) 
13 Ukuba kunjalo, amatyeli amangaphi phambi 
kokuba ufunyaniswe nale unayo i TB? 
Cacisa…………………….. 
14 Ingaba ufumana unyango lwe TB 
enganyangekiyo? 
Ewe      (            ) 
Hayi     (            ) 
15 Wawulaliswe esibhedlele ukuze ufunyansiwe 
une TB? 
Ewe      (           )  
Hayi     (           ) 
 
Iimpawu ozivayo 
No Questions (Imibuzo) 
Response (Impendulo) 
16 Nceda xela iimpawu zakho zokuqala, ngaphambi kokuba ufunyansiwe 
une sifo se TB (beka unxa ecaleni kwempendulo) 
Ukhohlo-khohlo olungaphantsi kwentsuku 
ezimbini 
(         ) 
Ukhohlo-khohlo olungaphezu kwentsuku 
ezimbini 
(         ) 
Ukukhohlela igazi (         ) 
Iintlungu zesifuba (         ) 
Iphika (         ) 
Ukubila ebusuku, nokuba sekubanda (         ) 
Ifiva (         ) 
Ukudinwa (         ) 
Ukwehla komzimba (ukubhitya) (         ) 
Ukungafuni ukutya (         ) 
Ezinye(cacisa)………………………………….  
……………………………………… 
17 Nceda bhala zonke ezinye iimpawu owawunazo phambi kokuba ufunyansiwe 
usesifo se 
TB………………………………………………………………………………………
………………….. 
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………. 
 
Indlela zokuzinyanga, isizathu sokukhetha indawo yokuqala owafuna kuyo 
uncedo, noncedo owalufumanayo 
N
o 
Imibuzo Bhala impendulo yakho apha
1
8 
Ngeyiphi into owawucinga ukuba ugula yiyo ngexesha owawusiva impawu 
ze TB? 
Ndandicinga ukuba ndino gawulayo/HIV                                    (               ) 
Ndandicinga ukuba ndinengqele/ ifiva                                         (               ) 
Ndandicinga ukuba ndineTB                                                        (               ) 
Ndandicinga ukuba sesinye isigulo                                              (               ) 
Ndandicinga ukuba ndithakathiwe                                               (               ) 
Ndandicinga ukuba ndiyaphazimiseka engqondweni                   (               ) 
Ndandingayazi ukuba ndigula yintoni                                           (               ) 
ezinye(cacisa)………………………………………….……………………………………
……………. 
1
9 
Wayokufuna uncedo lwezempilo 
ngokukhawuleza emva kokuba ubenempawu ze 
TB? 
Ewe     (         ) 
Hayi    (         ) 
2
0 
Ukuba zange uye ngokukhawuleza, yintoni eyenza ukuba ulinde ungayi? 
ungakhetha impendulo enye nangaphezulu 
Ndandicinga ukuba ndizakuphila ngaphandle konyango                                             
(         ) 
Ndandisoyika kuthwe ndinesifo se TB                                                                         
(         ) 
Ndandisoyika ukuhlekwa ndibelikheswa ekuhlaleni ngenxa xa kuthwe ndine TB      
(         ) 
Ndandingenamali                                                                                                          
(         ) 
Ndandisoyika ukuvavanyelwa  ugawulayo/ HIV                                                          
(         ) 
Akukho sizathu                                                                                                              
(         ) 
Ndandixakekile                                                                                                             
(         ) 
Ezinye izizathu  
(cacisa)………………………………………………………………………………………
.  
2
1 
Ngeyiphi kwezi ndawo zilandelayo, owaya 
kuzo  ukuqala kwakho ukuva iimpawo 
zesigulo se TB? 
 Ekliniki                                             
(       )  
 Esibhedlele sika rhulumente            
(       ) 
 Kwagqirha osecaleni - 
ohlawulelwayo  (       ) 
2
2 
Khetha izizathu ezabangela ukuba uye kule kliniki/ sibhedlele waya kuso? 
(ungakhetha ngaphezu kwesinye) 
Yayikufuphi apho ndihlala khona                       (           ) 
Ndandiyazi ukuba ndizakufumana uncedo     (           ) 
Ndacetyiswa  sisihlobo/ isizalwane                   (           ) 
Ndathunyelwa yenye ikliniki/ esibhedlele     (           ) 
Ndandingazukubhathala                                  (           ) 
Kwakungekho sizathu                                  (           ) 
Ezinye 
(cacisa)………………………………………………………………………………………
…….. 
2
3 
Xela zonke ezinye izizathu ezabangela ukuba ungayi kwezinye ikliniki/ 
isibhedlele (ungakhetha sibe sinye nangaphezulu) 
 
Zandicinge ukuba ndizakufumana uncedo                              (          ) 
Kukude apho ndihlala khona                                                   (          ) 
Kuhlala kukho abantu baninzi abalindileyo (que)                   (          ) 
Ndakhe ndaya andafumana ncedo luxolisayo                          (          ) 
Andiyithandi indela abasebenzi bapha abaziphethe ngayo      (          ) 
Akukho sizathu                                                                         (         ) 
Ezinye (cacisa)…………………………… 
2
4 
Wathatha ixesha elingakanani Ukuqala nje 
kwakho ukuva iimpawo ze TB phambi kokuba 
uye ekliniki/sibhedlele okanye kwqhirha, lo 
umkhethileyo ku no. 21 
Phakathi kosuku olunye ukuya 
kwezintandathu                               
(         ) 
Emva kweveki enye ukuya 
kwezimbini       (         ) 
Emva kweveki ezimbini  ukuya 
kwezine         (         ) 
Emva kwenyanga eziyi 2 -3            
(         ) 
Emva kwenyanga eziyi 2 - 4           
(         ) 
Emva kwenyanga eziyi 4, 
nangaphezulu          (         ) 
 
Ukuba kungaphezu kwenyanga 
ezie cacisa ixesha….. 
2
5 
Nceda xela zonke iimpawu owaye wazixelela unesi/ugqirha ukuqala kwakho 
ukuyokufuna uncedo  
Ukhohlo-khohlo olungaphantsi 
kwentsuku ezimbini 
(         ) 
Ukhohlo-khohlo olungaphezu 
kwentsuku ezimbini 
(         ) 
Ukukhohlela igazi (         ) 
Iintlungu zesifuba (         ) 
Iphika (         ) 
Ukubila ebusuku, nokuba sekubanda (         ) 
Ifiva (         ) 
Ukudinwa (         ) 
Ukwehla komzimba (         ) 
Ezinye (cacisa)………………………………….  ……………………………………… 
2
6 
kwenzeka ntoni kwintsuku zakho zokuqala usiya e kliniki/ esibhedlele/ 
okanye kwa griqha, le mpendulo  uyikhethe ku namba 21, (ungakhetha 
izizathu ezingaphezu kwesinye) 
 
Zange uzixele zonke iimpawu (          ) 
Ndanikwa ipilisi (antibiotics)  (          ) 
Kwathiwa mandinikezele iskhohlela (          ) 
Izikhohlela ezibini zazingenazo iimpawu 
ze TB 
 (          ) 
Kwathiwa mandiye kwi X-ray   (          ) 
Andisakhumbuli     (         ) 
Ezinye  chaza  ………………………………………………. …………………………       
 
2
7 
Zathatha ixesha elingakanani iziphumo zoxilongo lwe TB, emva kokuba zithathiwe 
izikhohlela?  
Ndazifumana kwintsuku ezimbini              (           ) 
Emva kwentsuku ezimbini                         (           ) 
2
8 
Ukuba impendulo yakho ithi kwakusemva 
kwentsuku ezimbini, yayiyiyintoni isizathu? 
Ewe Hayi 
 
Zange ndiye e kliniki emva kokuba isikhohlea 
sithathiwe   
  
 
Zange ndiye ngexesha ukuyokuthatha ingxelo 
(results)   
  
Usuku endandilinikwe ukuba mandiyokuthatha ingxelo 
lwalungaphezu  kwentsuku ezimbini   
  
Ezinye 
izizathu(cacisa)……………………………………………………………………………
…… 
2
9 
Phakathi kwe kliniki, esibhedlele okanye 
kwagqirha ohlawulelwayo, yeyiphi indawo 
ekwafunyaniswa kuyo ukuba une 
 TB? 
 
Ekliniki                                          
(          ) 
Esibhedlele                                   
(          ) 
Kwagqirha ohlawulelwayo             
(         ) 
 
3
0 
Kuthathe ixesha elingakani ukuba 
ufumane unyango, emva kokuya kwakho 
okokuqala ekliniki, sibhedlele, okanye 
ugqirha (impendulo oyikhethileyo ku 22) 
Kwintsuku ezimbini                                      
(         ) 
Kwintsuku ezintathu ukuya 
kwezintandathu   (         ) 
Kwiveki enye ukuya kwezimbini  1 – 2        
(         ) 
Kwiveki ezimbini ukuya kwezine  2 - 4        
(        ) 
Kwinyanga enye ukuya  kwezimbini 1- 2  
(        ) 
Kwinyanga ezimbini ukuya kwezine 2 -4  
(       ) 
Emva kwenyanga eziyi 4, nangaphezulu    
(         ) 
 
Ukuba kungaphezu kwenyanga ezine 
cacisa…………. 
3
1 
Waya amatyeli amangaphi ekliniki, okanye esibhedlele okanye kwagqirha  usisa 
impawu zesifo sephepha phambi kokuba ifumaneke/ bayibone kuwe i TB?  
.................. 
3
2 
Ukuqala kwakho ukuva impawu zeTB, wafuna awaphi amancedo kula 
angezantsi? (bhala ngokolulandelalelana kwawo (umzekelo 1st , 2nd, etc) 
 
Waya exhweleni                                      (        ) 
Waya kumthandazeli                               (        ) 
Wasela amayeza esintu                            (        ) 
Wasela amayeza asekhemesti                  (        ) 
Zange wenze nanye kwezi zingentla       (        ) 
Ezinye ( 
cacisa)………………………………………………………………………...........................
........ 
 
Inxaxheba yesebe lezempilo ukulumkisa uluntu malunga nesifo sephepha/ 
imbono/izimvo zesigulana   
N0 Imibuzo Bhala impendulo 
yakho apha 
33 Wawuyazi ukuba sikhona isifo sephepha phambi 
kokuba ufunyansiwe unaso? 
Ewe      (       ) 
Hayi      (       ) 
34 Ukuba wawuyazi, wawuve ngabani/ njani? Phambi kokuba ufunyaniswe 
une TB, ungakhetha iimpendulo enye nangapehzulu 
Ngabantu basekhaya  okanye izihlobo                                            (         ) 
Kwi radio/ TV, nasemaphepheni                                                    (         ) 
Onompilo/nontlalo  ekuhlaleni                                                        (         ) 
Xa ndisekliniki kunikezelwa iingcebiso                                           (         ) 
Enye indlela (cacisa)  
……………………………………………………………………………. 
35 Ngeziphi izinto eziyinyaniso malunga ne TB 
kwezi zilandelayo (khetha, u ewe/hayi/andiyazi) 
Ewe  Hay
i 
Andiyazi 
I TB yenziwa yintsholongwane    
I TB yenziwa yimimoya emdaka (ubugqwirha)    
ITB  iyanyangeka    
I TB iyasulela    
I TB iyafumaneka ngokwemfuzo (umzekelo, ukuba 
umzali wakho wayenayo nawe uzakubanayo) 
   
Amadoda kufuneka azinyange ngokwawo  
(ingakumbi xa engekaguli kakhulu) 
   
 
Ukubandlululwa kwabantu abanesifo se TB (khetha u ewe, hayi, andiyazi) 
No Imibuzo EWE HAYI ANDIYAZI
36  
Ndiziva ndinentloni ngokuba nesifo se TB 
   
Andifuni abanye abantu bazi ukuba 
ndinesifo se TB 
   
I TB iyayichaphazele kakubi  indlela 
endihlala ngayo nabanye abantu 
   
I TB iyayichaphazela kakubi  indlela 
endisebenza ngayo emsebenzini 
   
Wonke umntu one TB unesifo sika 
gawulayo 
   
Mancinci amathuba okuba umntu 
obhinqileyo one TB angatshata 
   
Andifuni kuba secaleni komntu one TB    
Kuyacalulwa/ kukho unukunezwa 
malunga nokuya e kliniki ye TB 
   
    
 
Ukufumana uncedo lwezempilo 
  Imibuzo Khetha impendulo 
yakho apha 
37 Ukhwela ntoni xausuka ekhaya usiya kwi 
kliniki/isibhedlele esikufutshane? 
Ndiya ngenyawo          
(        ) 
Ndisebenzisa i taxi      
(        )                            
ndinesam isithuthi       
(        ) 
39 Kuthatha ixesha elingakanani ukusuka ekhaya usiya 
ekliniki/sibhedlele usebenzisa ngesithuthi 
osisebenzisayo 
imizizu engaphantsi 
kwi 15 (        ) 
15-30 imizuzu                
(        ) 
 30-60 imizuzu               
(        ) 
imizuzu   engaphezu 
ku 60  (        ) 
Uphando malunga nesebe lezempilo  kuMasipala wase Makana  
39. wawuhlala apha e Makana ukuqala kwakho ukuva impawo zesifo sephepha? 
EWE  (         )                                  HAYI (         ) 
40.  Wawuhlala apha e Makana ukufunyaniswa kwakho unesifo sephepha?   
EWE   (       )                                 HAYI   (        ) 
  
 
 
 
 
 
 
 
 
 
 
